{"gene":"SHANK3","run_date":"2026-06-10T07:46:31","timeline":{"discoveries":[{"year":1999,"finding":"SHANK3 (ProSAP2) PDZ domain directly binds SAPAP/GKAP family proteins, as demonstrated by yeast two-hybrid, co-immunoprecipitation, and co-transfection in HEK cells, establishing SHANK3 as a link between SAP90/PSD-95-bound membrane receptors and the cytoskeleton at glutamatergic synapses.","method":"Yeast two-hybrid, co-immunoprecipitation, co-transfection in HEK cells","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus yeast two-hybrid and co-transfection, replicated across multiple orthogonal methods in a focused study","pmids":["10527873"],"is_preprint":false},{"year":2005,"finding":"Postsynaptic targeting of ProSAP2/SHANK3 in hippocampal neurons requires the integrity of the C-terminus, specifically a region encompassing the SAM domain; removal of 54 residues from the N-terminus of the minimal targeting construct resulted in diffuse cytoplasmic distribution, defining a novel C-terminal synaptic targeting signal.","method":"GFP-tagged deletion constructs expressed in hippocampal neurons, live imaging","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional consequence (synaptic vs. diffuse), single lab, two complementary constructs","pmids":["15659222"],"is_preprint":false},{"year":2006,"finding":"ProSAPiP1 is a novel binding partner of ProSAP2/SHANK3 PDZ domain; the complex co-immunoprecipitates and co-localizes at excitatory spines/synapses, and ProSAPiP1 links SPAR to synapses via ProSAP2/SHANK3, adding a new node to the PSD scaffold network.","method":"Co-immunoprecipitation, co-localization by confocal microscopy, yeast two-hybrid","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus co-localization, single lab, multiple methods","pmids":["16522626"],"is_preprint":false},{"year":2007,"finding":"Tissue-specific expression of SHANK3 (but not SHANK1 or SHANK2) is regulated by DNA methylation of its CpG islands: CpG islands are hypermethylated in tissues with low/absent SHANK3 protein and unmethylated in expressing tissues; SHANK3 protein is reduced in hippocampal neurons after methionine treatment and induced in HeLa cells after 5-Aza-2′-deoxycytidine treatment.","method":"Bisulfite sequencing, methionine treatment, 5-Aza-2′-deoxycytidine treatment, western blot","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal epigenetic and pharmacological experiments establishing a direct causal mechanism, single lab","pmids":["17419801"],"is_preprint":false},{"year":2011,"finding":"Shank3 deletion in mice causes defects at striatal synapses and cortico-striatal circuits, demonstrating a critical role for SHANK3 in neuronal connectivity; electrophysiological and biochemical analyses revealed reduced postsynaptic density proteins at striatal synapses.","method":"Genetic mouse model (Shank3 deletion), electrophysiology, biochemical PSD fractionation, behavioral analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, biochemistry, behavior) in a defined genetic loss-of-function model, highly cited","pmids":["21423165"],"is_preprint":false},{"year":2011,"finding":"Loss of major Shank3 isoforms (exons 4-9 deletion) reduces synaptic levels of Homer1b/c, GKAP, and GluA1 at the PSD and attenuates activity-dependent redistribution of GluA1-containing AMPA receptors, impairing LTP in CA1 hippocampus.","method":"Genetic mouse model, PSD biochemical fractionation, western blot, electrophysiology (LTP recordings), immunofluorescence","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods in a defined genetic model, independently consistent with other Shank3 mouse models","pmids":["21558424"],"is_preprint":false},{"year":2011,"finding":"A C-terminal deletion mutation of Shank3 (Shank3ΔC) causes the mutant protein to interact with wild-type Shank3 and promote its polyubiquitination and redistribution to proteasomes, resulting in >90% reduction of Shank3 at synapses; similarly, the NR1 subunit of NMDA receptor shows increased polyubiquitination and reduced synaptic levels, leading to reduced NMDAR-dependent LTP and LTD and enhanced mGluR-dependent LTD.","method":"Genetic mouse model, co-immunoprecipitation, polyubiquitination assay, electrophysiology (LTP/LTD recordings), proteasome fractionation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reconstitution of ubiquitination mechanism, multiple orthogonal methods, defined genetic model","pmids":["21565394"],"is_preprint":false},{"year":2011,"finding":"SHANK3 knockdown in neuronal cultures specifically reduces synaptic expression of mGluR5 (but not other major synaptic proteins), impairs mGluR5-dependent ERK1/2 and CREB phosphorylation, impairs mGluR5-dependent LTD, and reduces mEPSC frequency; these effects are rescued by a positive allosteric modulator of mGluR5.","method":"RNAi knockdown in neuronal cultures, western blot, immunofluorescence, electrophysiology (mEPSC recording, LTD), ERK/CREB phosphorylation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, biochemistry, pharmacological rescue) in a well-controlled knockdown model","pmids":["21795692"],"is_preprint":false},{"year":2011,"finding":"Zinc sequestration by amyloid-beta prevents association of Zn2+ ions with ProSAP2/SHANK3, leading to reduced ProSAP2/Shank3 at the PSD and decreased synapse density; zinc supplementation or pre-saturation of Aβ with zinc countered these effects, demonstrating zinc-dependent regulation of SHANK3 scaffold assembly.","method":"Cell-based Zn2+ binding assay, rat hippocampal cultures, zinc supplementation, immunofluorescence, synapse density quantification, APP-PS1 mouse model","journal":"Molecular neurodegeneration","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple in vitro and in vivo assays in single lab, zinc-SHANK3 interaction confirmed by cell-based assay","pmids":["21939532"],"is_preprint":false},{"year":2012,"finding":"Synaptic levels of ProSAP2/SHANK3 regulate AMPA and NMDA receptor-mediated synaptic transmission and modulate presynaptic structure/function through Neurexin-Neuroligin transsynaptic signaling; ASD-associated mutations in SHANK3 disrupt both postsynaptic receptor signaling and transsynaptic signaling.","method":"Overexpression and knockdown in rat hippocampal neurons, electrophysiology (AMPAR/NMDAR EPSCs), immunofluorescence of pre/postsynaptic proteins","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple electrophysiological and biochemical readouts, single lab, defined pathway placement","pmids":["23100419"],"is_preprint":false},{"year":2013,"finding":"SHANK3 expression restores excitatory synaptic transmission deficits in iPSC-derived neurons from Phelan-McDermid syndrome patients; IGF1 treatment promotes formation of mature excitatory synapses lacking SHANK3 but containing PSD95 and NMDA receptors, demonstrating SHANK3's role in excitatory synapse function in human neurons.","method":"iPSC-derived neurons from PMDS patients, lentiviral SHANK3 re-expression, IGF1 treatment, electrophysiology (synaptic transmission recordings), immunofluorescence","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — human iPSC model with genetic rescue and pharmacological rescue, multiple orthogonal methods","pmids":["24132240"],"is_preprint":false},{"year":2013,"finding":"Shank3 deficiency induces NMDA receptor hypofunction via actin cytoskeleton disruption through the Rac1/PAK/cofilin signaling pathway; Shank3 siRNA reduces NR1 surface expression and NMDAR currents, effects blocked by actin stabilizers and constitutively active Rac1 or PAK, and occluded by Rac1/PAK inhibitors or cofilin activation.","method":"siRNA knockdown in rat cortical cultures, whole-cell patch clamp (NMDAR currents), surface biotinylation, immunocytochemistry (F-actin), pharmacological manipulation of Rac1/PAK/cofilin pathway","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple pharmacological epistasis experiments plus electrophysiology plus surface expression assays establishing pathway mechanism","pmids":["24089484"],"is_preprint":false},{"year":2013,"finding":"Rich2 (Rho-GAP interacting CIP4 homolog 2) is a new Shank3 binding partner identified by proteomics; Rich2-Shank3 interaction increases in dendritic spines during LTP; Rich2 controls AMPA receptor GluA1 exocytosis; disruption of the Rich2-Shank3 complex inhibits spine enlargement and GluA1 exocytosis during LTP.","method":"Proteomic screen, BRET microscopy, siRNA knockdown, interfering mimetic peptide, AMPA receptor exocytosis assay, spine morphology analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — proteomic identification confirmed by BRET, functional disruption via siRNA and peptide, multiple orthogonal readouts","pmids":["23739967"],"is_preprint":false},{"year":2013,"finding":"ProSAP2/Shank3 undergoes activity-dependent synapse-to-nucleus shuttling in hippocampal neurons; a schizophrenia-associated de novo mutation (R1117X) causes constitutive nuclear accumulation independent of synaptic activity and alters transcription of schizophrenia risk genes (Synaptotagmin 1, LRRTM1), identifying novel nuclear interaction partners.","method":"Immunofluorescence, live imaging, activity manipulation (TTX/bicuculline), nuclear/synaptic fractionation, transcriptional analysis","journal":"Experimental neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with functional consequence (transcriptional changes), single lab, multiple readouts","pmids":["24382453"],"is_preprint":false},{"year":2013,"finding":"The Shank3 ankyrin repeat region is regulated by an intramolecular interaction with the adjacent SPN (Shank/ProSAP N-terminal) domain, which restricts access of ligands Sharpin and α-fodrin; ASD-associated L68P mutation disrupts this intramolecular blockade, resulting in a gain-of-function with enhanced binding to these ligands.","method":"Binding assays in heterologous cells, expression of wild-type and mutant Shank3 in neurons, electrophysiology (rescue experiments after knockdown)","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional binding assays with mutagenesis plus electrophysiological validation, single lab","pmids":["23897824"],"is_preprint":false},{"year":2014,"finding":"Shank3 gene displays extensive mRNA and protein isoforms from multiple intragenic promoters and alternative splicing; isoform expression is brain-region/cell-type specific, developmentally regulated, activity-dependent, and epigenetically controlled; different Shank3 isoforms show distinct subcellular distributions and differential effects on dendritic spine morphology in hippocampal neurons.","method":"RT-PCR, quantitative real-time RT-PCR, western blot, cellular imaging of isoform-specific GFP constructs in hippocampal neurons","journal":"Molecular autism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (RT-PCR, qPCR, western, imaging) with direct functional comparisons of isoforms, single lab","pmids":["25071925"],"is_preprint":false},{"year":2015,"finding":"SHANK3 interacts with TRPV1 via its proline-rich region in dorsal root ganglion sensory neurons and regulates TRPV1 surface expression; Shank3 haploinsufficiency reduces capsaicin-induced spontaneous pain, DRG neuron inward currents, and spinal cord synaptic currents, establishing a peripheral mechanistic role for SHANK3 in pain signaling.","method":"Co-immunoprecipitation (SHANK3-TRPV1), surface expression assay, patch clamp electrophysiology, conditional knockout (Nav1.8-Cre), behavioral pain assays","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, surface expression, electrophysiology, and conditional KO with specific behavioral readout, multiple orthogonal methods","pmids":["27916453"],"is_preprint":false},{"year":2016,"finding":"SHANK3 mutations severely and specifically impair hyperpolarization-activated cation (Ih) channels; SHANK3 protein interacts with HCN channel proteins (HCN1, HCN2, HCN4); chronic pharmacological blockage of Ih channels reproduces SHANK3 mutation phenotypes (altered neuronal morphology and synaptic connectivity), suggesting Ih channelopathy mediates downstream effects.","method":"Engineered conditional mutations in human neurons, electrophysiology (Ih current recording), co-immunoprecipitation (SHANK3-HCN), pharmacological Ih blockade, mouse Shank3-deficient neurons","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP identifying interaction, electrophysiology in human engineered neurons and mouse neurons, pharmacological phenocopy, multiple orthogonal methods","pmids":["26966193"],"is_preprint":false},{"year":2016,"finding":"Shank3 deficiency causes down-regulation of Akt-mTORC1 signaling through enhanced phosphorylation and activation of PP2A regulatory subunit B56β due to increased steady-state levels of its kinase CLK2; pharmacological/genetic Akt activation or CLK2 inhibition relieves synaptic deficits in Shank3-deficient and PMDS patient-derived neurons.","method":"Quantitative phosphoproteomics, pharmacological and genetic manipulation (CLK2 inhibition, Akt activation), electrophysiology in patient iPSC-derived neurons, behavioral assays in Shank3-deficient mice","journal":"Science","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — unbiased phosphoproteomics plus genetic and pharmacological validation in both mouse and human neurons, multiple orthogonal methods","pmids":["26847545"],"is_preprint":false},{"year":2016,"finding":"Re-expression of Shank3 in adult mice (after developmental absence) improves synaptic protein composition, spine density, and neural function in the striatum, and rescues social interaction deficits and repetitive grooming, but not anxiety or motor coordination deficits, demonstrating partial reversibility of Shank3-dependent phenotypes.","method":"Conditional knock-in mouse model (inducible Shank3 re-expression), western blot, spine density analysis, electrophysiology, behavioral assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue in adult animals with multiple synaptic and behavioral readouts, well-controlled mouse model","pmids":["26886798"],"is_preprint":false},{"year":2016,"finding":"Shank3 deficiency increases nuclear localization of β-catenin (a Shank3-binding protein), which induces HDAC2 upregulation and social deficits; HDAC2 knockdown in PFC rescues social deficits; romidepsin (HDAC inhibitor) treatment elevates expression and histone acetylation of Grin2a and actin-regulatory genes, restoring NMDA-receptor function and actin filaments.","method":"Co-immunoprecipitation (Shank3-β-catenin), nuclear fractionation, HDAC2 knockdown, HDAC inhibitor treatment, NMDA receptor electrophysiology, ChIP (histone acetylation), behavioral assays","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, nuclear fractionation, genetic knockdown, pharmacological rescue, and electrophysiology establishing pathway mechanism","pmids":["29531362"],"is_preprint":false},{"year":2016,"finding":"Zinc stabilizes Shank3 at the postsynaptic density; zinc supplementation increases Shank3 labeling intensity at PSD and prevents reversal of NMDA-induced Shank3 accumulation, demonstrated by pre-embedding immunogold electron microscopy.","method":"Pre-embedding immunogold electron microscopy, depolarization (high K+) and NMDA treatment, zinc supplementation in dissociated rat hippocampal cultures","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ultrastructural localization with quantitative analysis, functional manipulation, single lab","pmids":["27144302"],"is_preprint":false},{"year":2017,"finding":"Shank3 protein interaction with ZIP4 (zinc uptake transporter) was demonstrated by co-immunoprecipitation; SHANK3-deficient enterocytes show decreased expression of ZIP2 and ZIP4 correlating with SHANK3 levels, and reduced ZIP4 co-localizes with SHANK3 at the plasma membrane, identifying a role for SHANK3 in intestinal zinc homeostasis.","method":"Co-immunoprecipitation (ZIP4-SHANK3), SHANK3 knockdown in Caco-2 cells, iPSC-derived enterocytes from PMDS patients, immunohistochemistry in Shank3αβ KO mice","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing complex, knockdown and KO model, multiple model systems, single lab","pmids":["28345660"],"is_preprint":false},{"year":2017,"finding":"SHANK3 regulates intestinal barrier function by modulating ZO-1 expression through a PKCε-dependent pathway; SHANK3 overexpression enhances ZO-1 expression while knockdown reduces it; SHANK3 KO mice show leaky epithelial barrier.","method":"SHANK3 overexpression/knockdown in intestinal epithelial cells, SHANK3 KO mouse model, TEER/paracellular permeability assays, western blot (ZO-1, PKCε), immunoblotting","journal":"Inflammatory bowel diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional manipulation (OE and KD) with defined molecular readout (ZO-1/PKCε) and in vivo KO confirmation, single lab","pmids":["28906292"],"is_preprint":false},{"year":2018,"finding":"USP8 is a deubiquitinating enzyme that regulates SHANK3 ubiquitination and protein levels; USP8 enhances SHANK3 and SHANK1 protein levels via deubiquitination, increases dendritic spine density, and is essential for activity-dependent changes in SHANK3 protein levels.","method":"Co-immunoprecipitation (USP8-SHANK3), ubiquitination assay, USP8 overexpression/knockdown in primary rat neurons, western blot, dendritic spine analysis","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, deubiquitination assay, and bidirectional manipulation with functional readout (spine density, protein levels), single lab","pmids":["29735556"],"is_preprint":false},{"year":2019,"finding":"An ASD-linked missense variant at Shank3 S685 disrupts recruitment of ABI1 and the WAVE complex to the PSD, impairing synapse and dendritic spine development; this function is independent of Shank3's binding to GKAP and Homer, demonstrating modular independent functions of Shank3.","method":"In vivo phosphorylation profiling, co-immunoprecipitation (Shank3-ABI1/WAVE complex), knock-in mouse model with S685 mutation, dendritic spine analysis, behavioral assays","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing interaction, knock-in mouse model with behavioral and morphological readout, single lab","pmids":["30610205"],"is_preprint":false},{"year":2019,"finding":"Conditional knockout of Shank3 in the anterior cingulate cortex (ACC) is sufficient to cause excitatory synaptic dysfunction and social interaction deficits; selective enhancement of ACC activity, SHANK3 restoration in ACC, or systemic AMPA receptor-positive modulator administration improved social behavior in Shank3 mutant mice.","method":"Conditional knockout (region-specific Cre), electrophysiology (excitatory synaptic transmission), behavioral assays, pharmacological rescue","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — circuit-selective genetic manipulation with defined synaptic and behavioral readouts, pharmacological rescue confirms pathway","pmids":["31332372"],"is_preprint":false},{"year":2019,"finding":"ERK2 binds Shank3 directly and phosphorylates it at three residues to promote poly-ubiquitination-dependent degradation; genetic deletion or pharmacological inhibition of ERK2 increases Shank3 protein abundance in vivo.","method":"Kinome-wide siRNA screen, ERK2-Shank3 co-immunoprecipitation/binding, phosphorylation assay, ubiquitination assay, in vivo pharmacological/genetic ERK2 inhibition, western blot","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct binding, phosphorylation, and ubiquitination assays with in vivo validation, multiple orthogonal methods","pmids":["30696942"],"is_preprint":false},{"year":2019,"finding":"SHANK3 mutations increase histone methyltransferases EHMT1/2 and H3K9me2 in prefrontal cortex; EHMT1/2 inhibition or knockdown rescues autism-like social deficits and restores NMDAR-mediated synaptic function; Arc was identified as a causal downstream factor for NMDAR function rescue.","method":"Western blot (EHMT1/2, H3K9me2 in Shank3 KD mice and human postmortem brains), EHMT1/2 inhibitor (UNC0642) treatment, EHMT knockdown in PFC, electrophysiology (NMDAR currents), behavioral assays","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — convergent evidence from pharmacological and genetic inhibition, human postmortem confirmation, electrophysiology, and behavioral rescue","pmids":["30659288"],"is_preprint":false},{"year":2020,"finding":"SHANK3 localizes to Z-discs in skeletal muscle sarcomeres and co-immunoprecipitates with α-ACTININ; SHANK3 deficiency leads to shortened Z-discs, impaired acetylcholine receptor clustering at neuromuscular junctions, and motor deficits rescued by troponin activator Tirasemtiv.","method":"Co-immunoprecipitation (SHANK3-α-ACTININ), immunofluorescence (Z-disc localization), hiPSC-derived myotubes, Shank3Δ11-/- mice, PMDS patient muscle biopsies, behavioral rescue with Tirasemtiv","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP establishing interaction, direct localization in multiple model systems including patient tissue, pharmacological rescue","pmids":["32522805"],"is_preprint":false},{"year":2020,"finding":"CaMKIIα directly binds Shank3 between residues 829–1130; mutation of Shank3 residues 949Arg-Arg-Lys951 to alanines disrupts CaMKII binding; both Shank3 binding to CaMKII and to LTCCs is required for depolarization-induced CREB phosphorylation and c-Fos expression, establishing Shank3 as a required scaffold for LTCC-to-nucleus signaling.","method":"Co-immunoprecipitation from mouse forebrain, direct binding assay with purified CaMKIIα, site-directed mutagenesis, shRNA/rescue in hippocampal neurons, CREB phosphorylation and c-Fos expression assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct binding with purified protein, mutagenesis disrupting interaction, shRNA/rescue establishing functional requirement, multiple orthogonal methods","pmids":["32019829"],"is_preprint":false},{"year":2020,"finding":"Truncating mutations in SHANK3 that remove postsynaptic targeting sequences expose a nuclear localization signal in the N-terminal part of the protein; truncated SHANK3 interacts with β-catenin via the PDZ domain of SHANK3 and armadillo repeats of β-catenin, sequestering both in nuclear bodies and strongly repressing β-catenin-dependent transcriptional activation.","method":"Subcellular localization analysis (immunofluorescence, fractionation), co-immunoprecipitation (truncated Shank3-β-catenin), luciferase transcriptional reporter assays, NLS identification and mutagenesis","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, direct localization, functional reporter assay establishing transcriptional repression, single lab","pmids":["32202324"],"is_preprint":false},{"year":2021,"finding":"Two ASD-associated missense mutations in SHANK3 cause distinct changes in secondary and tertiary protein structure, increased conformational fluctuations (by SAXS and biophysical analysis), and result in altered synaptic targeting and changes in protein turnover at synaptic sites in rat primary hippocampal neurons.","method":"SAXS, biophysical structural analysis, FRAP in rat hippocampal neurons, synaptic localization analysis","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — structural analysis (SAXS) plus neuronal functional experiments, single lab","pmids":["33945465"],"is_preprint":false},{"year":2021,"finding":"SHANK3 directly interacts with actin through its SPN domain; this interaction is inhibited by an intramolecular closed conformation where the adjacent ARR domain covers the actin-binding interface; actin and Rap1 compete for binding to SHANK3; SHANK3-actin interaction regulates dendritic spine morphology in neurons.","method":"Molecular simulations, targeted mutagenesis, actin co-sedimentation assay, co-immunoprecipitation, dendritic spine morphology analysis in neurons, integrin activity assay in cancer cells","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct binding assay, mutagenesis confirming interface, molecular simulations, and neuronal functional validation","pmids":["34610274"],"is_preprint":false},{"year":2022,"finding":"Phosphorylation of Shank3 at S1586 and S1615 bidirectionally gates homeostatic synaptic scaling: sites are hypophosphorylated during scaling up (via PP2A activity) and hyperphosphorylated during scaling down; phosphomimetic mutations prevent scaling up while phosphodeficient mutations prevent scaling down; these phosphorylation states modify Shank3 synaptic localization.","method":"Deep-scale quantitative phosphoproteomics, immunoaffinity isolation, phosphomimetic/phosphodeficient mutagenesis, PP2A pharmacological inhibition, synaptic scaling assay, Shank3 synaptic localization analysis in neocortical neurons","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — phosphoproteomics combined with mutagenesis, pharmacological intervention, and functional assays in a single integrated study","pmids":["35471151"],"is_preprint":false},{"year":2022,"finding":"SHANK3 interacts with STIM1 via direct binding and promotes proteasome-mediated degradation of STIM1; STIM1 downregulation via SHANK3 induces Nrf2 Ser40 phosphorylation, Nrf2 nuclear translocation, and upregulation of antioxidant genes (NQO1, HO-1), protecting against ischemia/reperfusion-induced oxidative stress and inflammation.","method":"Co-immunoprecipitation (Shank3-STIM1), Shank3 conditional KO and double KO (Shank3+Stim1), western blot (Nrf2, NQO1, HO-1), in vitro HT22 cell assays, in vivo I/R mouse model","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing interaction, genetic rescue with double KO validating pathway, single lab","pmids":["38064762"],"is_preprint":false},{"year":2022,"finding":"CTTNBP2 facilitates SHANK3 co-condensation at dendritic spines through liquid-liquid phase separation; zinc binding to CTTNBP2 promotes liquid-to-gel phase transition, reducing CTTNBP2 mobility and enhancing stability/synaptic retention of CTTNBP2-SHANK3 condensates.","method":"Co-condensation assays, FRAP, phase separation assays, zinc supplementation, ASD mutation analysis, behavioral assays in mice","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct condensate co-assembly assays, FRAP, and in vivo behavioral validation, single lab","pmids":["35562389"],"is_preprint":false},{"year":2022,"finding":"ADNP interacts with SHANK3 and actin in mouse brain extracts; NAP (ADNP-derived peptide) normalizes Shank3-Adnp-actin interactions as shown by actin co-immunoprecipitation, and NAP treatment ameliorates behavior in Shank3 InsG3680 mutant mice.","method":"Co-immunoprecipitation (Shank3-Adnp-actin) from mouse brain, NAP treatment, behavioral assays in Shank3 InsG3680 mice","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing three-way complex, pharmacological rescue confirming functional relationship, single lab","pmids":["35538192"],"is_preprint":false},{"year":2022,"finding":"Cardiac Shank3 directly binds CaMKII (demonstrated by IP assay), and this interaction increases in the aged heart; enhanced Shank3/CaMKII binding impedes mitochondrial translocation of CaMKII, inhibiting Parkin-mediated mitophagy and causing mitochondrial dysfunction and cardiac damage.","method":"Co-immunoprecipitation (cardiac Shank3-CaMKII), cardiac-specific Shank3 conditional KO, mitophagy assays, mitochondrial function assays","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing interaction, conditional KO establishing functional role in cardiac mitophagy, single lab","pmids":["36436456"],"is_preprint":false},{"year":2023,"finding":"Shank3 in vagal sensory neurons (nodose ganglion) regulates TRPM2 expression; Shank3 deficiency in Nav1.8-expressing sensory neurons or selective Shank3 knockdown in vagal neurons impairs body temperature regulation and increases LPS-induced systemic inflammation (IL-6), identifying a peripheral, non-synaptic role for SHANK3.","method":"Conditional Shank3 KO (Nav1.8-Cre), Shank3/Trpm2 knockdown in nodose ganglion, RNAscope in situ hybridization, LPS inflammation model, body temperature measurement","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO plus selective knockdown with defined molecular readout (TRPM2 expression), functional inflammatory phenotype, single lab","pmids":["36845137"],"is_preprint":false},{"year":2009,"finding":"ProSAPiP2 is a novel binding partner of ProSAP2/SHANK3 PDZ domain, expressed in neurons, localized to dendrites and spines and enriched in the PSD; it interacts with actin, potentially linking PSD components to the cytoskeleton.","method":"Co-immunoprecipitation, immunofluorescence, PSD fractionation, actin binding assay","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP and co-localization, limited functional follow-up, single lab","pmids":["19481056"],"is_preprint":false},{"year":2015,"finding":"miR-7, miR-34a, and miR-504 post-transcriptionally regulate SHANK3 expression through direct binding sites in the 3' UTR; overexpression or inhibition of miR-7 and miR-504 affected dendritic spines in hippocampal neurons in a Shank3-dependent manner.","method":"Luciferase reporter assay (miRNA 3' UTR binding), lentiviral miRNA overexpression in hippocampal neurons, western blot, spine morphology analysis","journal":"Molecular brain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase assay confirming direct 3' UTR binding, functional validation in neurons via lentiviral overexpression, single lab","pmids":["26572867"],"is_preprint":false},{"year":2018,"finding":"Shank3 deficiency causes Ih channelopathy in thalamocortical neurons; Shank3 increases HCN channel surface expression in heterologous systems; Shank3Δ13-16 deficiency causes reduction in HCN2 expression and Ih current amplitude, altered resting membrane potential, increased input resistance, and abnormal spike firing—phenotypes resembling HCN2-/- TC neurons.","method":"Heterologous expression of Shank3 isoforms with HCN channels (surface expression assay), electrophysiology (Ih current recording) in thalamocortical neurons from Shank3 KO mice, comparison with HCN2-/- mice","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — surface expression assay plus electrophysiology in specific neuronal type, confirmed by phenotypic comparison with HCN2 KO, multiple isoform comparison","pmids":["29327340"],"is_preprint":false},{"year":2024,"finding":"Shank3 mutation (InsG3680) impairs glutamatergic signaling in oligodendrocytes and reduces expression of myelination-related transcripts and proteins in vivo; SHANK3 has a postsynaptic role in oligodendrocyte precursor cells similar to its role in neurons, and SHANK3 deficiency impairs myelin ultrastructure and axonal conductivity.","method":"InsG3680 mouse model, iPSC-derived OLs from patient with InsG3680 mutation, electrophysiology (OPC glutamatergic responses), western blot, electron microscopy (myelin ultrastructure), axonal conductivity measurement","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods including patient-derived cells, in vivo and in vitro validation, single lab","pmids":["39392881"],"is_preprint":false},{"year":2025,"finding":"Shank3 SAM domain-mediated oligomerization is essential for the PSD condensate to form a glass-like material state through network percolation; disruption of Shank3 SAM oligomerization softens the PSD condensate, impairs synaptic transmission and plasticity, and causes autistic-like behavior in mice; reconstituted PSD condensate forms a soft glass material without irreversible amyloid structure.","method":"Reconstituted PSD condensate (in vitro phase separation), rheology (material property measurement), SAM domain oligomerization mutagenesis, electrophysiology (synaptic transmission/plasticity), behavioral assays in knock-in mice","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution of PSD condensate with rheological characterization, mutagenesis establishing mechanism, in vivo genetic validation with synaptic and behavioral readouts","pmids":["40848728"],"is_preprint":false}],"current_model":"SHANK3 is a multi-domain postsynaptic scaffold protein at excitatory synapses whose SAM domain drives oligomerization and glass-like PSD condensate formation; it organizes glutamate receptor complexes (NMDAR, AMPAR, mGluR5) and HCN channels via direct interactions with GKAP/SAPAP, Homer, neuroligins, HCN proteins, CaMKII, TRPV1, ABI1/WAVE complex, and actin (through its SPN domain), while its synaptic levels are dynamically regulated by zinc, activity-dependent phosphorylation (ERK2-mediated ubiquitin-proteasome degradation, PP2A-mediated dephosphorylation gating homeostatic scaling, and USP8-mediated deubiquitination), epigenetic mechanisms (DNA methylation, HDAC2/EHMT1/2-dependent histone modifications), and miRNAs; outside the CNS, SHANK3 also regulates peripheral pain (via TRPV1 surface expression in DRG neurons), intestinal barrier function (via PKCε-ZO-1 pathway), zinc transporter expression in enterocytes, vagal neuron temperature/immune regulation (via TRPM2), and skeletal muscle sarcomere integrity (via α-ACTININ at Z-discs)."},"narrative":{"mechanistic_narrative":"SHANK3 (ProSAP2) is a master postsynaptic scaffold of excitatory glutamatergic synapses that physically links membrane receptors to the actin cytoskeleton and, through self-assembly, organizes the material properties of the postsynaptic density (PSD) [PMID:10527873, PMID:40848728]. Its PDZ domain binds the SAPAP/GKAP family to bridge PSD-95-associated receptors to deeper scaffold and cytoskeletal layers [PMID:10527873], while SAM domain-mediated oligomerization drives the PSD to behave as a glass-like condensate whose stiffness is required for normal synaptic transmission and plasticity [PMID:40848728]. Loss of SHANK3 reduces synaptic Homer1b/c, GKAP, GluA1, mGluR5 and NMDAR subunits and impairs LTP/LTD, AMPAR redistribution, and mGluR5-dependent signaling [PMID:21558424, PMID:21565394, PMID:21795692], in part by disrupting Rac1/PAK/cofilin-dependent actin dynamics and NMDAR surface expression [PMID:24089484]; SHANK3 also binds actin directly through its SPN domain under conformational control by the adjacent ARR domain [PMID:34610274]. Beyond passive scaffolding, SHANK3 couples synaptic activity to the nucleus, serving as a required adaptor for CaMKIIα- and L-type calcium channel-driven CREB phosphorylation and c-Fos induction [PMID:32019829], and it nucleates dynamic signaling complexes with Rich2, the ABI1/WAVE complex, HCN channels, and CTTNBP2 to control spine morphology, AMPAR exocytosis, Ih currents, and zinc-tuned condensate stability [PMID:23739967, PMID:30610205, PMID:26966193, PMID:35562389]. SHANK3 abundance at synapses is tightly regulated by zinc binding [PMID:21939532, PMID:27144302], by ubiquitin-proteasome turnover controlled by ERK2-mediated phosphorylation and USP8-mediated deubiquitination [PMID:30696942, PMID:29735556], by PP2A-gated phosphorylation that bidirectionally controls homeostatic scaling [PMID:35471151], and by DNA methylation, miRNAs, and downstream chromatin-modifying pathways (β-catenin/HDAC2, EHMT1/2) [PMID:17419801, PMID:26572867, PMID:29531362, PMID:30659288]. SHANK3 deficiency models Phelan-McDermid syndrome and autism-associated phenotypes, with synaptic and behavioral deficits reversible by re-expression of SHANK3 or pharmacological restoration of downstream pathways [PMID:24132240, PMID:26886798, PMID:31332372]. Outside the CNS, SHANK3 performs analogous scaffolding roles, regulating TRPV1 in nociceptors [PMID:27916453], TRPM2 in vagal neurons [PMID:36845137], intestinal barrier and zinc transport [PMID:28345660, PMID:28906292], skeletal muscle Z-disc integrity via α-ACTININ [PMID:32522805], and cardiac mitophagy via CaMKII [PMID:36436456].","teleology":[{"year":1999,"claim":"Establishing how postsynaptic receptors couple to deeper scaffold and cytoskeleton, the discovery that SHANK3's PDZ domain binds SAPAP/GKAP positioned SHANK3 as the physical link between PSD-95-bound receptors and the cytoskeleton.","evidence":"Yeast two-hybrid, reciprocal Co-IP, and co-transfection in HEK cells","pmids":["10527873"],"confidence":"High","gaps":["Did not define higher-order scaffold assembly","No in vivo functional consequence shown"]},{"year":2005,"claim":"To explain how SHANK3 is delivered to synapses, deletion mapping identified a C-terminal SAM-domain-containing targeting signal required for postsynaptic localization.","evidence":"GFP-tagged deletion constructs and live imaging in hippocampal neurons","pmids":["15659222"],"confidence":"Medium","gaps":["Molecular partners mediating targeting not identified","Mechanism of SAM-dependent targeting not resolved"]},{"year":2007,"claim":"Addressing why SHANK3 is expressed tissue-specifically, CpG island methylation was shown to causally control SHANK3 (but not SHANK1/2) protein levels.","evidence":"Bisulfite sequencing with methionine and 5-Aza-2′-deoxycytidine pharmacology and western blot","pmids":["17419801"],"confidence":"High","gaps":["Methyl-binding effectors not identified","Link to disease-relevant expression changes not established"]},{"year":2011,"claim":"Genetic loss-of-function mouse and knockdown studies established SHANK3 as essential for excitatory synapse composition, plasticity, and circuit function, defining its role in striatal/cortico-striatal connectivity and receptor-specific deficits (Homer1b/c, GKAP, GluA1, mGluR5, NMDAR).","evidence":"Multiple Shank3 deletion mouse models with electrophysiology, PSD fractionation, and RNAi rescue","pmids":["21423165","21558424","21565394","21795692"],"confidence":"High","gaps":["Different exon deletions yield partially distinct phenotypes","Isoform-specific contributions not yet separated"]},{"year":2011,"claim":"To explain how SHANK3 mutations destabilize the scaffold, a C-terminal truncation was shown to drive polyubiquitination and proteasomal redistribution of wild-type SHANK3 and NMDAR NR1, linking mutation to dominant scaffold loss.","evidence":"Co-IP, polyubiquitination assays, and LTP/LTD electrophysiology in a Shank3ΔC mouse","pmids":["21565394"],"confidence":"High","gaps":["E3 ligase not identified at this stage","Generalizability to other truncations unknown"]},{"year":2011,"claim":"Identifying an upstream regulator of scaffold assembly, zinc was shown to be required for SHANK3 PSD localization, with amyloid-beta-mediated zinc sequestration reducing synaptic SHANK3 and synapse density.","evidence":"Cell-based Zn2+ binding assays, hippocampal cultures, and APP-PS1 mice with zinc supplementation","pmids":["21939532"],"confidence":"Medium","gaps":["Zinc-binding site on SHANK3 not mapped here","Stoichiometry of zinc effect unclear"]},{"year":2013,"claim":"Expanding the partner network, proteomic and binding studies identified Rich2 and clarified intramolecular autoinhibition (SPN–ARR) controlling Sharpin/α-fodrin access, linking SHANK3 conformation to spine plasticity and AMPAR exocytosis.","evidence":"Proteomic screen, BRET, interfering peptides, and binding assays with ASD mutants","pmids":["23739967","23897824"],"confidence":"High","gaps":["Regulation of the conformational switch in vivo not defined","Cross-talk between ligand sets not resolved"]},{"year":2013,"claim":"Establishing transsynaptic and nuclear roles, SHANK3 was shown to modulate Neurexin-Neuroligin presynaptic function and to undergo activity-dependent synapse-to-nucleus shuttling that alters transcription, with a schizophrenia mutation causing constitutive nuclear accumulation.","evidence":"Overexpression/knockdown electrophysiology and nuclear/synaptic fractionation with transcriptional analysis","pmids":["23100419","24382453"],"confidence":"Medium","gaps":["Nuclear interaction partners incompletely defined","Physiological significance of shuttling in vivo unclear"]},{"year":2013,"claim":"To resolve how SHANK3 controls NMDAR function, knockdown was shown to drive NMDAR hypofunction through Rac1/PAK/cofilin-mediated actin disruption and reduced NR1 surface expression.","evidence":"siRNA knockdown, surface biotinylation, and pharmacological epistasis on the Rac1/PAK/cofilin pathway","pmids":["24089484"],"confidence":"High","gaps":["Direct biochemical link between SHANK3 and Rac1/PAK not shown","Whether actin effect is direct or scaffold-mediated unclear"]},{"year":2013,"claim":"Human-cell validation: SHANK3 re-expression restored excitatory transmission deficits in Phelan-McDermid syndrome iPSC neurons, and IGF1 provided a SHANK3-independent rescue, anchoring SHANK3 function in human disease neurons.","evidence":"PMDS patient iPSC neurons with lentiviral SHANK3 rescue, IGF1 treatment, and electrophysiology","pmids":["24132240"],"confidence":"High","gaps":["Mechanism of IGF1 bypass not defined","Long-term/in vivo translatability unaddressed"]},{"year":2014,"claim":"Characterizing SHANK3 complexity, multiple intragenic promoters and splicing were shown to generate isoforms with distinct localization, regulation, and spine effects, explaining cell-type and activity specificity.","evidence":"RT-PCR, qPCR, western blot, and imaging of isoform-specific GFP constructs","pmids":["25071925"],"confidence":"Medium","gaps":["Functional roles of individual isoforms incompletely mapped","Isoform-specific partner repertoires unknown"]},{"year":2015,"claim":"Post-transcriptional control of SHANK3 was established via direct miRNA targeting of its 3'UTR (miR-7, miR-34a, miR-504), affecting spine morphology in a SHANK3-dependent manner.","evidence":"Luciferase 3'UTR reporters and lentiviral miRNA manipulation in hippocampal neurons","pmids":["26572867"],"confidence":"Medium","gaps":["Physiological contexts engaging each miRNA unclear","In vivo relevance not tested"]},{"year":2015,"claim":"Extending SHANK3 beyond the CNS, its proline-rich region was shown to bind TRPV1 and regulate TRPV1 surface expression in DRG neurons, defining a peripheral role in pain signaling.","evidence":"Co-IP, surface expression assays, conditional Nav1.8-Cre knockout, and behavioral pain assays","pmids":["27916453"],"confidence":"High","gaps":["Whether scaffolding mechanism mirrors CNS PSD role unclear","Other peripheral TRPV1 contexts untested"]},{"year":2016,"claim":"SHANK3 was shown to bind HCN channel subunits and control Ih currents, identifying an Ih channelopathy as a downstream mediator of SHANK3 mutation phenotypes.","evidence":"Co-IP, Ih electrophysiology in engineered human and mouse neurons, and pharmacological Ih blockade phenocopy","pmids":["26966193","29327340"],"confidence":"High","gaps":["Domain mediating HCN binding not fully mapped","Relative contribution of Ih vs glutamatergic deficits unclear"]},{"year":2016,"claim":"Mechanistic and therapeutic insight into reversibility came from Akt-mTORC1/PP2A-B56β/CLK2 signaling deficits and adult SHANK3 re-expression rescuing synaptic and select behavioral phenotypes.","evidence":"Phosphoproteomics with genetic/pharmacological CLK2-Akt manipulation, and inducible adult Shank3 re-expression mouse","pmids":["26847545","26886798"],"confidence":"High","gaps":["Why some phenotypes (anxiety, motor) are irreversible unknown","Direct vs indirect link of SHANK3 to PP2A/CLK2 unresolved"]},{"year":2016,"claim":"Linking SHANK3 to chromatin, β-catenin/HDAC2 signaling was shown to mediate social deficits, with HDAC inhibition restoring NMDAR function and actin gene expression.","evidence":"Co-IP, nuclear fractionation, HDAC2 knockdown, romidepsin treatment, ChIP, and behavior","pmids":["29531362"],"confidence":"High","gaps":["How synaptic SHANK3 loss elevates nuclear β-catenin not fully defined","Direct chromatin targets incompletely cataloged"]},{"year":2017,"claim":"Peripheral epithelial roles emerged: SHANK3 binds ZIP4 to control intestinal zinc transport and regulates barrier integrity through a PKCε-ZO-1 pathway.","evidence":"Co-IP, knockdown in Caco-2/iPSC enterocytes, and Shank3 KO mice with permeability assays","pmids":["28345660","28906292"],"confidence":"Medium","gaps":["Mechanism connecting SHANK3 to PKCε not defined","Relationship between zinc transport and barrier roles unclear"]},{"year":2018,"claim":"USP8 was identified as a deubiquitinase stabilizing SHANK3, establishing reversible ubiquitination as a control point for activity-dependent SHANK3 levels and spine density.","evidence":"Co-IP, deubiquitination assays, and bidirectional USP8 manipulation in rat neurons","pmids":["29735556"],"confidence":"Medium","gaps":["E3 ligase counterpart not jointly defined here","Activity signals driving USP8 engagement unclear"]},{"year":2019,"claim":"The kinase coupling SHANK3 degradation to signaling was identified as ERK2, which directly binds and phosphorylates SHANK3 to promote ubiquitin-dependent turnover, complementing modular roles defined by the S685/ABI1-WAVE axis.","evidence":"Kinome-wide screen, binding/phosphorylation/ubiquitination assays, in vivo ERK2 inhibition, and S685 knock-in mouse with Co-IP","pmids":["30696942","30610205"],"confidence":"High","gaps":["Identity of the E3 ligase remains undefined","Interplay between ERK2 phosphosites and other regulatory sites unclear"]},{"year":2019,"claim":"Circuit- and chromatin-level mechanisms were refined: ACC-restricted SHANK3 loss is sufficient for social deficits rescuable by AMPAR potentiation, and EHMT1/2-driven H3K9me2 (via Arc) mediates NMDAR and behavioral deficits.","evidence":"Region-specific conditional KO with pharmacological rescue, and EHMT1/2 inhibition/knockdown with human postmortem confirmation and electrophysiology","pmids":["31332372","30659288"],"confidence":"High","gaps":["How synaptic SHANK3 loss elevates EHMT1/2 not defined","Generalizability across brain regions partially open"]},{"year":2020,"claim":"SHANK3 was established as a required adaptor for activity-to-nucleus signaling through direct CaMKIIα binding (residues 829–1130; RRK949-951) coupling LTCCs to CREB/c-Fos, and direct SPN-domain actin binding under ARR-conformational and Rap1-competitive control.","evidence":"Direct binding with purified CaMKIIα, mutagenesis, shRNA/rescue, actin co-sedimentation, and molecular simulations","pmids":["32019829","34610274"],"confidence":"High","gaps":["How conformational opening is triggered physiologically unclear","Integration of CaMKII and actin functions not unified"]},{"year":2020,"claim":"Non-neuronal scaffolding roles were defined in skeletal muscle, where SHANK3 binds α-ACTININ at Z-discs to maintain sarcomere and NMJ integrity, with pharmacological rescue of motor deficits.","evidence":"Co-IP, Z-disc immunofluorescence in myotubes, Shank3 mice, patient biopsies, and Tirasemtiv rescue","pmids":["32522805"],"confidence":"High","gaps":["Whether muscle role uses same domains as PSD scaffolding unclear","Contribution to PMDS motor phenotype quantification incomplete"]},{"year":2020,"claim":"The transcriptional-repression mechanism of truncated SHANK3 was clarified: truncations expose an N-terminal NLS, and the PDZ domain binds β-catenin armadillo repeats to sequester both in nuclear bodies and repress β-catenin transcription.","evidence":"Fractionation, Co-IP, NLS mutagenesis, and luciferase reporter assays","pmids":["32202324"],"confidence":"Medium","gaps":["In vivo relevance of nuclear sequestration not established","Target gene set repressed not defined"]},{"year":2021,"claim":"Biophysical analyses tied ASD missense mutations to altered protein structure, conformational flexibility, synaptic targeting, and turnover, connecting molecular destabilization to synaptic dysfunction.","evidence":"SAXS, biophysical structural analysis, and FRAP in rat hippocampal neurons","pmids":["33945465"],"confidence":"Medium","gaps":["High-resolution structures not determined","Direct link from conformational change to specific binding losses unclear"]},{"year":2022,"claim":"Phase-separation principles entered SHANK3 biology: CTTNBP2 promotes SHANK3 co-condensation, and zinc drives a liquid-to-gel transition stabilizing synaptic condensates, mechanistically integrating zinc regulation with material-state control.","evidence":"Co-condensation/phase separation assays, FRAP, zinc supplementation, and mouse behavior","pmids":["35562389"],"confidence":"Medium","gaps":["Relationship to SAM-domain oligomerization not unified here","Endogenous zinc dynamics governing transition unclear"]},{"year":2022,"claim":"Homeostatic plasticity control was assigned to PP2A-gated SHANK3 phosphorylation at S1586/S1615, which bidirectionally gates synaptic scaling and modifies SHANK3 synaptic localization.","evidence":"Deep-scale phosphoproteomics, phosphomimetic/phosphodeficient mutagenesis, PP2A inhibition, and scaling assays","pmids":["35471151"],"confidence":"High","gaps":["Kinase(s) opposing PP2A at these sites not identified","How phosphorylation alters localization mechanistically unclear"]},{"year":2022,"claim":"Additional peripheral and signaling roles were defined: SHANK3 binds STIM1 to promote its degradation and engage Nrf2 antioxidant signaling, binds cardiac CaMKII to regulate mitophagy, and forms ADNP-actin complexes amenable to NAP rescue.","evidence":"Co-IP, conditional/double KO models, mitophagy/oxidative assays, and NAP behavioral rescue","pmids":["38064762","36436456","35538192"],"confidence":"Medium","gaps":["Tissue-specific generality of these interactions unclear","Shared vs distinct domains used for each partner undefined"]},{"year":2023,"claim":"A vagal-neuron role was established whereby SHANK3 regulates TRPM2 expression to control body temperature and systemic inflammation, extending non-synaptic peripheral functions.","evidence":"Conditional KO, vagal knockdown, RNAscope, and LPS inflammation model","pmids":["36845137"],"confidence":"Medium","gaps":["Mechanism linking SHANK3 to TRPM2 transcription unclear","Direct physical interaction not demonstrated"]},{"year":2024,"claim":"SHANK3 function was extended to oligodendrocyte lineage cells, where mutation impairs glutamatergic signaling, myelination transcripts, myelin ultrastructure, and axonal conductivity, broadening its role beyond neurons.","evidence":"InsG3680 mice, patient iPSC-derived oligodendrocytes, electrophysiology, and electron microscopy","pmids":["39392881"],"confidence":"Medium","gaps":["Whether oligodendrocyte SHANK3 uses the same PSD machinery unclear","Contribution of myelin deficits to behavior not quantified"]},{"year":2025,"claim":"The unifying biophysical principle was established: SAM-domain oligomerization drives the PSD condensate into a glass-like material state via network percolation, and disrupting it softens the condensate, impairs plasticity, and causes autistic-like behavior.","evidence":"Reconstituted PSD condensate with rheology, SAM oligomerization mutagenesis, electrophysiology, and knock-in mouse behavior","pmids":["40848728"],"confidence":"High","gaps":["How material state mechanistically tunes receptor signaling unclear","Regulators of glass-state transition in vivo undefined"]},{"year":null,"claim":"How SHANK3's many regulatory inputs (zinc, phosphorylation, ubiquitination, conformational state, phase separation) are integrated in real time to set PSD composition and material properties, and which E3 ligase executes ERK2/ubiquitin-dependent degradation, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["E3 ligase for SHANK3 degradation unidentified","Unified model linking condensate material state to receptor signaling missing","Domain logic distinguishing CNS scaffolding from peripheral roles undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,30,33]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[33,11,29]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[16,17,42,35,22]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[44,36]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[16,22,17]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[13,31,20]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[33,11,29]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,4,5,6,7,44]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[30,18,11]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[6,27,24]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[20,28,3]}],"complexes":["postsynaptic density (PSD)","WAVE regulatory complex (ABI1/WAVE)"],"partners":["GKAP/SAPAP","HOMER1","CAMKII","HCN2","TRPV1","ACTN2 (Α-ACTININ)","CTNNB1 (Β-CATENIN)","CTTNBP2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9BYB0","full_name":"SH3 and multiple ankyrin repeat domains protein 3","aliases":["Proline-rich synapse-associated protein 2","ProSAP2"],"length_aa":1806,"mass_kda":191.3,"function":"Major scaffold postsynaptic density protein which interacts with multiple proteins and complexes to orchestrate the dendritic spine and synapse formation, maturation and maintenance. Interconnects receptors of the postsynaptic membrane including NMDA-type and metabotropic glutamate receptors via complexes with GKAP/PSD-95 and HOMER, respectively, and the actin-based cytoskeleton. Plays a role in the structural and functional organization of the dendritic spine and synaptic junction through the interaction with Arp2/3 and WAVE1 complex as well as the promotion of the F-actin clusters. By way of this control of actin dynamics, participates in the regulation of developing neurons growth cone motility and the NMDA receptor-signaling. Also modulates GRIA1 exocytosis and GRM5/MGLUR5 expression and signaling to control the AMPA and metabotropic glutamate receptor-mediated synaptic transmission and plasticity. May be required at an early stage of synapse formation and be inhibited by IGF1 to promote synapse maturation","subcellular_location":"Cytoplasm; Postsynaptic density; Cell projection, dendritic spine","url":"https://www.uniprot.org/uniprotkb/Q9BYB0/entry"},"depmap":{"release":"DepMap","has_data":false,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SHANK3"},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"NUMA1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/SHANK3","total_profiled":1310},"omim":[{"mim_id":"621185","title":"HOUGE-JANSSENS SYNDROME 4; HJS4","url":"https://www.omim.org/entry/621185"},{"mim_id":"619149","title":"LESSEL-KREIENKAMP SYNDROME; LESKRES","url":"https://www.omim.org/entry/619149"},{"mim_id":"616417","title":"ADHESION G PROTEIN-COUPLED RECEPTOR L3; ADGRL3","url":"https://www.omim.org/entry/616417"},{"mim_id":"615538","title":"CHROMOSOME 22q13 DUPLICATION SYNDROME","url":"https://www.omim.org/entry/615538"},{"mim_id":"614453","title":"LEUCINE-RICH REPEAT-CONTAINING PROTEIN 7; LRRC7","url":"https://www.omim.org/entry/614453"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":155.9},{"tissue":"lymphoid tissue","ntpm":119.5}],"url":"https://www.proteinatlas.org/search/SHANK3"},"hgnc":{"alias_symbol":["SPANK-2","prosap2","KIAA1650","PSAP2"],"prev_symbol":[]},"alphafold":{"accession":"Q9BYB0","domains":[{"cath_id":"3.10.20.90","chopping":"2-93","consensus_level":"medium","plddt":87.0814,"start":2,"end":93},{"cath_id":"1.25.40.20","chopping":"248-355","consensus_level":"medium","plddt":93.0545,"start":248,"end":355},{"cath_id":"2.30.42.10","chopping":"566-667","consensus_level":"high","plddt":88.3395,"start":566,"end":667},{"cath_id":"1.10.150.50","chopping":"1665-1730","consensus_level":"high","plddt":89.8829,"start":1665,"end":1730}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BYB0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYB0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYB0-F1-predicted_aligned_error_v6.png","plddt_mean":52.41},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SHANK3","jax_strain_url":"https://www.jax.org/strain/search?query=SHANK3"},"sequence":{"accession":"Q9BYB0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BYB0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BYB0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BYB0"}},"corpus_meta":[{"pmid":"21423165","id":"PMC_21423165","title":"Shank3 mutant mice display autistic-like behaviours and striatal dysfunction.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21423165","citation_count":1223,"is_preprint":false},{"pmid":"17173049","id":"PMC_17173049","title":"Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.","date":"2006","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17173049","citation_count":1168,"is_preprint":false},{"pmid":"21558424","id":"PMC_21558424","title":"Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21558424","citation_count":448,"is_preprint":false},{"pmid":"24132240","id":"PMC_24132240","title":"SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/24132240","citation_count":358,"is_preprint":false},{"pmid":"26886798","id":"PMC_26886798","title":"Adult restoration of Shank3 expression rescues selective autistic-like phenotypes.","date":"2016","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26886798","citation_count":316,"is_preprint":false},{"pmid":"12920066","id":"PMC_12920066","title":"Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.","date":"2003","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12920066","citation_count":293,"is_preprint":false},{"pmid":"26687841","id":"PMC_26687841","title":"Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects.","date":"2015","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/26687841","citation_count":266,"is_preprint":false},{"pmid":"26966193","id":"PMC_26966193","title":"Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons.","date":"2016","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/26966193","citation_count":263,"is_preprint":false},{"pmid":"23758760","id":"PMC_23758760","title":"Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency.","date":"2013","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/23758760","citation_count":263,"is_preprint":false},{"pmid":"18615476","id":"PMC_18615476","title":"Novel de novo SHANK3 mutation in autistic patients.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18615476","citation_count":257,"is_preprint":false},{"pmid":"11431708","id":"PMC_11431708","title":"Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11431708","citation_count":236,"is_preprint":false},{"pmid":"31332372","id":"PMC_31332372","title":"Anterior cingulate cortex dysfunction underlies social deficits in Shank3 mutant mice.","date":"2019","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31332372","citation_count":229,"is_preprint":false},{"pmid":"29531362","id":"PMC_29531362","title":"Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition.","date":"2018","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29531362","citation_count":190,"is_preprint":false},{"pmid":"31189958","id":"PMC_31189958","title":"Atypical behaviour and connectivity in SHANK3-mutant macaques.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31189958","citation_count":186,"is_preprint":false},{"pmid":"21795692","id":"PMC_21795692","title":"Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21795692","citation_count":160,"is_preprint":false},{"pmid":"10527873","id":"PMC_10527873","title":"Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10527873","citation_count":154,"is_preprint":false},{"pmid":"23100419","id":"PMC_23100419","title":"Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23100419","citation_count":148,"is_preprint":false},{"pmid":"28139198","id":"PMC_28139198","title":"Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28139198","citation_count":130,"is_preprint":false},{"pmid":"25071925","id":"PMC_25071925","title":"Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice.","date":"2014","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/25071925","citation_count":130,"is_preprint":false},{"pmid":"26847545","id":"PMC_26847545","title":"CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency.","date":"2016","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/26847545","citation_count":127,"is_preprint":false},{"pmid":"27916453","id":"PMC_27916453","title":"SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons.","date":"2016","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/27916453","citation_count":125,"is_preprint":false},{"pmid":"22749736","id":"PMC_22749736","title":"SHANK3 as an autism spectrum disorder-associated gene.","date":"2012","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/22749736","citation_count":120,"is_preprint":false},{"pmid":"26134648","id":"PMC_26134648","title":"Autism-Associated Insertion Mutation (InsG) of Shank3 Exon 21 Causes Impaired Synaptic Transmission and Behavioral Deficits.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26134648","citation_count":119,"is_preprint":false},{"pmid":"27021819","id":"PMC_27021819","title":"Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice.","date":"2016","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27021819","citation_count":105,"is_preprint":false},{"pmid":"15659222","id":"PMC_15659222","title":"C-terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15659222","citation_count":99,"is_preprint":false},{"pmid":"24089484","id":"PMC_24089484","title":"Shank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanism.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24089484","citation_count":98,"is_preprint":false},{"pmid":"21565394","id":"PMC_21565394","title":"Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21565394","citation_count":97,"is_preprint":false},{"pmid":"31061091","id":"PMC_31061091","title":"Deletion of Autism Risk Gene Shank3 Disrupts Prefrontal Connectivity.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31061091","citation_count":93,"is_preprint":false},{"pmid":"25894671","id":"PMC_25894671","title":"Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.","date":"2015","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25894671","citation_count":87,"is_preprint":false},{"pmid":"36202854","id":"PMC_36202854","title":"Modeling human telencephalic development and autism-associated SHANK3 deficiency using organoids generated from single neural rosettes.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36202854","citation_count":81,"is_preprint":false},{"pmid":"28948968","id":"PMC_28948968","title":"Stem cell-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic abnormalities during early development.","date":"2017","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28948968","citation_count":81,"is_preprint":false},{"pmid":"34784886","id":"PMC_34784886","title":"Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications.","date":"2021","source":"Journal of neurodevelopmental disorders","url":"https://pubmed.ncbi.nlm.nih.gov/34784886","citation_count":72,"is_preprint":false},{"pmid":"30973326","id":"PMC_30973326","title":"Shank3 modulates sleep and expression of circadian transcription factors.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30973326","citation_count":71,"is_preprint":false},{"pmid":"30659288","id":"PMC_30659288","title":"Amelioration of autism-like social deficits by targeting histone methyltransferases EHMT1/2 in Shank3-deficient mice.","date":"2019","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30659288","citation_count":68,"is_preprint":false},{"pmid":"27554343","id":"PMC_27554343","title":"The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutations.","date":"2016","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/27554343","citation_count":61,"is_preprint":false},{"pmid":"26045941","id":"PMC_26045941","title":"Phenotypic and functional analysis of SHANK3 stop mutations identified in individuals with ASD and/or ID.","date":"2015","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/26045941","citation_count":60,"is_preprint":false},{"pmid":"26572867","id":"PMC_26572867","title":"Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disorders.","date":"2015","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/26572867","citation_count":58,"is_preprint":false},{"pmid":"21939532","id":"PMC_21939532","title":"Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold.","date":"2011","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/21939532","citation_count":55,"is_preprint":false},{"pmid":"17419801","id":"PMC_17419801","title":"DNA methylation regulates tissue-specific expression of Shank3.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17419801","citation_count":55,"is_preprint":false},{"pmid":"23739967","id":"PMC_23739967","title":"Shank3-Rich2 interaction regulates AMPA receptor recycling and synaptic long-term potentiation.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23739967","citation_count":53,"is_preprint":false},{"pmid":"24382453","id":"PMC_24382453","title":"The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation.","date":"2013","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24382453","citation_count":51,"is_preprint":false},{"pmid":"30610205","id":"PMC_30610205","title":"An autism-linked missense mutation in SHANK3 reveals the modularity of Shank3 function.","date":"2019","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30610205","citation_count":51,"is_preprint":false},{"pmid":"24700646","id":"PMC_24700646","title":"Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/24700646","citation_count":50,"is_preprint":false},{"pmid":"16522626","id":"PMC_16522626","title":"ProSAP-interacting protein 1 (ProSAPiP1), a novel protein of the postsynaptic density that links the spine-associated Rap-Gap (SPAR) to the scaffolding protein ProSAP2/Shank3.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16522626","citation_count":49,"is_preprint":false},{"pmid":"28345660","id":"PMC_28345660","title":"Zinc deficiency and low enterocyte zinc transporter expression in human patients with autism related mutations in SHANK3.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28345660","citation_count":49,"is_preprint":false},{"pmid":"33468258","id":"PMC_33468258","title":"Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model.","date":"2021","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/33468258","citation_count":44,"is_preprint":false},{"pmid":"23897824","id":"PMC_23897824","title":"SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23897824","citation_count":42,"is_preprint":false},{"pmid":"32522805","id":"PMC_32522805","title":"Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated muscles.","date":"2020","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32522805","citation_count":42,"is_preprint":false},{"pmid":"38064762","id":"PMC_38064762","title":"Shank3 ameliorates neuronal injury after cerebral ischemia/reperfusion via inhibiting oxidative stress and inflammation.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38064762","citation_count":41,"is_preprint":false},{"pmid":"26319514","id":"PMC_26319514","title":"PsAP2 an AP2/ERF family transcription factor from Papaver somniferum enhances abiotic and biotic stress tolerance in transgenic tobacco.","date":"2015","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26319514","citation_count":39,"is_preprint":false},{"pmid":"35538192","id":"PMC_35538192","title":"SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.","date":"2022","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/35538192","citation_count":38,"is_preprint":false},{"pmid":"32327468","id":"PMC_32327468","title":"Early Restoration of Shank3 Expression in Shank3 Knock-Out Mice Prevents Core ASD-Like Behavioral Phenotypes.","date":"2020","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/32327468","citation_count":38,"is_preprint":false},{"pmid":"35675770","id":"PMC_35675770","title":"Neural circuit pathology driven by Shank3 mutation disrupts social behaviors.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35675770","citation_count":38,"is_preprint":false},{"pmid":"33126897","id":"PMC_33126897","title":"Differentially altered social dominance- and cooperative-like behaviors in Shank2- and Shank3-mutant mice.","date":"2020","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/33126897","citation_count":36,"is_preprint":false},{"pmid":"32019829","id":"PMC_32019829","title":"Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIα-Shank3 Interaction.","date":"2020","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32019829","citation_count":36,"is_preprint":false},{"pmid":"37657643","id":"PMC_37657643","title":"Acetate supplementation rescues social deficits and alters transcriptional regulation in prefrontal cortex of Shank3 deficient mice.","date":"2023","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/37657643","citation_count":35,"is_preprint":false},{"pmid":"35726031","id":"PMC_35726031","title":"SHANK3 deficiency leads to myelin defects in the central and peripheral nervous system.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/35726031","citation_count":34,"is_preprint":false},{"pmid":"36436456","id":"PMC_36436456","title":"Ablation of Shank3 alleviates cardiac dysfunction in aging mice by promoting CaMKII activation and Parkin-mediated mitophagy.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/36436456","citation_count":34,"is_preprint":false},{"pmid":"28371232","id":"PMC_28371232","title":"Investigation of SHANK3 in schizophrenia.","date":"2017","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28371232","citation_count":33,"is_preprint":false},{"pmid":"35562389","id":"PMC_35562389","title":"Phase separation and zinc-induced transition modulate synaptic distribution and association of autism-linked CTTNBP2 and SHANK3.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35562389","citation_count":33,"is_preprint":false},{"pmid":"29735556","id":"PMC_29735556","title":"USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29735556","citation_count":33,"is_preprint":false},{"pmid":"28906292","id":"PMC_28906292","title":"SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway.","date":"2017","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28906292","citation_count":33,"is_preprint":false},{"pmid":"33203459","id":"PMC_33203459","title":"Altered synaptic ultrastructure in the prefrontal cortex of Shank3-deficient rats.","date":"2020","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/33203459","citation_count":32,"is_preprint":false},{"pmid":"30537371","id":"PMC_30537371","title":"Genotype and phenotype correlations for SHANK3 de novo mutations in neurodevelopmental disorders.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30537371","citation_count":30,"is_preprint":false},{"pmid":"25882257","id":"PMC_25882257","title":"MicroRNA-7/Shank3 axis involved in schizophrenia pathogenesis.","date":"2015","source":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","url":"https://pubmed.ncbi.nlm.nih.gov/25882257","citation_count":29,"is_preprint":false},{"pmid":"32015180","id":"PMC_32015180","title":"Subacute Neuropsychiatric Syndrome in Girls With SHANK3 Mutations Responds to Immunomodulation.","date":"2020","source":"Pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32015180","citation_count":29,"is_preprint":false},{"pmid":"29327340","id":"PMC_29327340","title":"Shank3-deficient thalamocortical neurons show HCN channelopathy and alterations in intrinsic electrical properties.","date":"2018","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29327340","citation_count":28,"is_preprint":false},{"pmid":"27144302","id":"PMC_27144302","title":"Zinc Stabilizes Shank3 at the Postsynaptic Density of Hippocampal Synapses.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27144302","citation_count":27,"is_preprint":false},{"pmid":"34703011","id":"PMC_34703011","title":"Rescue of histone hypoacetylation and social deficits by ketogenic diet in a Shank3 mouse model of autism.","date":"2021","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34703011","citation_count":26,"is_preprint":false},{"pmid":"35471151","id":"PMC_35471151","title":"A bidirectional switch in the Shank3 phosphorylation state biases synapses toward up- or downscaling.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35471151","citation_count":25,"is_preprint":false},{"pmid":"35716826","id":"PMC_35716826","title":"A cross-talk between nitric oxide and the glutamatergic system in a Shank3 mouse model of autism.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35716826","citation_count":25,"is_preprint":false},{"pmid":"37528484","id":"PMC_37528484","title":"Shank3 deletion in PV neurons is associated with abnormal behaviors and neuronal functions that are rescued by increasing GABAergic signaling.","date":"2023","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/37528484","citation_count":24,"is_preprint":false},{"pmid":"30868621","id":"PMC_30868621","title":"Autism-associated Shank3 mutations alter mGluR expression and mGluR-dependent but not NMDA receptor-dependent long-term depression.","date":"2019","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30868621","citation_count":24,"is_preprint":false},{"pmid":"35682760","id":"PMC_35682760","title":"Deletion of the Autism-Associated Protein SHANK3 Abolishes Structural Synaptic Plasticity after Brain Trauma.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35682760","citation_count":24,"is_preprint":false},{"pmid":"31788990","id":"PMC_31788990","title":"Severe white matter damage in SHANK3 deficiency: a human and translational study.","date":"2019","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31788990","citation_count":24,"is_preprint":false},{"pmid":"33262327","id":"PMC_33262327","title":"Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment.","date":"2020","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33262327","citation_count":24,"is_preprint":false},{"pmid":"19566951","id":"PMC_19566951","title":"Association study of SHANK3 gene polymorphisms with autism in Chinese Han population.","date":"2009","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19566951","citation_count":24,"is_preprint":false},{"pmid":"36056598","id":"PMC_36056598","title":"Shank3 influences mammalian sleep development.","date":"2022","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/36056598","citation_count":23,"is_preprint":false},{"pmid":"20800661","id":"PMC_20800661","title":"Proline-rich synapse-associated protein-1 and 2 (ProSAP1/Shank2 and ProSAP2/Shank3)-scaffolding proteins are also present in postsynaptic specializations of the peripheral nervous system.","date":"2010","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20800661","citation_count":23,"is_preprint":false},{"pmid":"37848710","id":"PMC_37848710","title":"Modeling SHANK3-associated autism spectrum disorder in Beagle dogs via CRISPR/Cas9 gene editing.","date":"2023","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/37848710","citation_count":23,"is_preprint":false},{"pmid":"35444258","id":"PMC_35444258","title":"Dormant state of quiescent neural stem cells links Shank3 mutation to autism development.","date":"2022","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/35444258","citation_count":23,"is_preprint":false},{"pmid":"30696942","id":"PMC_30696942","title":"A kinome-wide RNAi screen identifies ERK2 as a druggable regulator of Shank3 stability.","date":"2019","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30696942","citation_count":23,"is_preprint":false},{"pmid":"27329942","id":"PMC_27329942","title":"Activity and circadian rhythm influence synaptic Shank3 protein levels in mice.","date":"2016","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27329942","citation_count":22,"is_preprint":false},{"pmid":"29052348","id":"PMC_29052348","title":"Shank3-deficient rats exhibit degraded cortical responses to sound.","date":"2017","source":"Autism research : official journal of the International Society for Autism Research","url":"https://pubmed.ncbi.nlm.nih.gov/29052348","citation_count":22,"is_preprint":false},{"pmid":"33945465","id":"PMC_33945465","title":"Autism-associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33945465","citation_count":21,"is_preprint":false},{"pmid":"32202324","id":"PMC_32202324","title":"Truncating mutations in SHANK3 associated with global developmental delay interfere with nuclear β-catenin signaling.","date":"2020","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32202324","citation_count":21,"is_preprint":false},{"pmid":"31773410","id":"PMC_31773410","title":"Neural Stem Cells from Shank3-ko Mouse Model Autism Spectrum Disorders.","date":"2019","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/31773410","citation_count":21,"is_preprint":false},{"pmid":"34453663","id":"PMC_34453663","title":"Shank3 Deficiency is Associated With Altered Profile of Neurotransmission Markers in Pups and Adult Mice.","date":"2021","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/34453663","citation_count":21,"is_preprint":false},{"pmid":"24164323","id":"PMC_24164323","title":"Identification of two novel Shank3 transcripts in the developing mouse neocortex.","date":"2013","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24164323","citation_count":20,"is_preprint":false},{"pmid":"34610274","id":"PMC_34610274","title":"SHANK3 conformation regulates direct actin binding and crosstalk with Rap1 signaling.","date":"2021","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/34610274","citation_count":19,"is_preprint":false},{"pmid":"39392881","id":"PMC_39392881","title":"Shank3 mutation impairs glutamate signaling and myelination in ASD mouse model and human iPSC-derived OPCs.","date":"2024","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/39392881","citation_count":18,"is_preprint":false},{"pmid":"19481056","id":"PMC_19481056","title":"ProSAPiP2, a novel postsynaptic density protein that interacts with ProSAP2/Shank3.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19481056","citation_count":17,"is_preprint":false},{"pmid":"26511836","id":"PMC_26511836","title":"Novel Therapeutic Approach for Autism Spectrum Disorder: Focus on SHANK3.","date":"2015","source":"Current neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26511836","citation_count":17,"is_preprint":false},{"pmid":"40848728","id":"PMC_40848728","title":"Shank3 oligomerization governs material properties of the postsynaptic density condensate and synaptic plasticity.","date":"2025","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/40848728","citation_count":16,"is_preprint":false},{"pmid":"36311023","id":"PMC_36311023","title":"Age, brain region, and gene dosage-differential transcriptomic changes in Shank3-mutant mice.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36311023","citation_count":16,"is_preprint":false},{"pmid":"34921227","id":"PMC_34921227","title":"Restoring Shank3 in the rostral brainstem of shank3ab-/- zebrafish autism models rescues sensory deficits.","date":"2021","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/34921227","citation_count":16,"is_preprint":false},{"pmid":"37008785","id":"PMC_37008785","title":"Excessive self-grooming, gene dysregulation and imbalance between the striosome and matrix compartments in the striatum of Shank3 mutant mice.","date":"2023","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37008785","citation_count":16,"is_preprint":false},{"pmid":"34504419","id":"PMC_34504419","title":"Expression of the Excitatory Postsynaptic Scaffolding Protein, Shank3, in Human Brain: Effect of Age and Alzheimer's Disease.","date":"2021","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34504419","citation_count":16,"is_preprint":false},{"pmid":"27271042","id":"PMC_27271042","title":"The association of SHANK3 gene polymorphism and autism.","date":"2016","source":"Minerva pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27271042","citation_count":15,"is_preprint":false},{"pmid":"36845137","id":"PMC_36845137","title":"SHANK3 in vagal sensory neurons regulates body temperature, systemic inflammation, and sepsis.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36845137","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51750,"output_tokens":11378,"usd":0.16296,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22562,"output_tokens":8918,"usd":0.16788,"stage2_stop_reason":"end_turn"},"total_usd":0.33084,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"SHANK3 (ProSAP2) PDZ domain directly binds SAPAP/GKAP family proteins, as demonstrated by yeast two-hybrid, co-immunoprecipitation, and co-transfection in HEK cells, establishing SHANK3 as a link between SAP90/PSD-95-bound membrane receptors and the cytoskeleton at glutamatergic synapses.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, co-transfection in HEK cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus yeast two-hybrid and co-transfection, replicated across multiple orthogonal methods in a focused study\",\n      \"pmids\": [\"10527873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Postsynaptic targeting of ProSAP2/SHANK3 in hippocampal neurons requires the integrity of the C-terminus, specifically a region encompassing the SAM domain; removal of 54 residues from the N-terminus of the minimal targeting construct resulted in diffuse cytoplasmic distribution, defining a novel C-terminal synaptic targeting signal.\",\n      \"method\": \"GFP-tagged deletion constructs expressed in hippocampal neurons, live imaging\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional consequence (synaptic vs. diffuse), single lab, two complementary constructs\",\n      \"pmids\": [\"15659222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ProSAPiP1 is a novel binding partner of ProSAP2/SHANK3 PDZ domain; the complex co-immunoprecipitates and co-localizes at excitatory spines/synapses, and ProSAPiP1 links SPAR to synapses via ProSAP2/SHANK3, adding a new node to the PSD scaffold network.\",\n      \"method\": \"Co-immunoprecipitation, co-localization by confocal microscopy, yeast two-hybrid\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus co-localization, single lab, multiple methods\",\n      \"pmids\": [\"16522626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Tissue-specific expression of SHANK3 (but not SHANK1 or SHANK2) is regulated by DNA methylation of its CpG islands: CpG islands are hypermethylated in tissues with low/absent SHANK3 protein and unmethylated in expressing tissues; SHANK3 protein is reduced in hippocampal neurons after methionine treatment and induced in HeLa cells after 5-Aza-2′-deoxycytidine treatment.\",\n      \"method\": \"Bisulfite sequencing, methionine treatment, 5-Aza-2′-deoxycytidine treatment, western blot\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal epigenetic and pharmacological experiments establishing a direct causal mechanism, single lab\",\n      \"pmids\": [\"17419801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Shank3 deletion in mice causes defects at striatal synapses and cortico-striatal circuits, demonstrating a critical role for SHANK3 in neuronal connectivity; electrophysiological and biochemical analyses revealed reduced postsynaptic density proteins at striatal synapses.\",\n      \"method\": \"Genetic mouse model (Shank3 deletion), electrophysiology, biochemical PSD fractionation, behavioral analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, biochemistry, behavior) in a defined genetic loss-of-function model, highly cited\",\n      \"pmids\": [\"21423165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Loss of major Shank3 isoforms (exons 4-9 deletion) reduces synaptic levels of Homer1b/c, GKAP, and GluA1 at the PSD and attenuates activity-dependent redistribution of GluA1-containing AMPA receptors, impairing LTP in CA1 hippocampus.\",\n      \"method\": \"Genetic mouse model, PSD biochemical fractionation, western blot, electrophysiology (LTP recordings), immunofluorescence\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods in a defined genetic model, independently consistent with other Shank3 mouse models\",\n      \"pmids\": [\"21558424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A C-terminal deletion mutation of Shank3 (Shank3ΔC) causes the mutant protein to interact with wild-type Shank3 and promote its polyubiquitination and redistribution to proteasomes, resulting in >90% reduction of Shank3 at synapses; similarly, the NR1 subunit of NMDA receptor shows increased polyubiquitination and reduced synaptic levels, leading to reduced NMDAR-dependent LTP and LTD and enhanced mGluR-dependent LTD.\",\n      \"method\": \"Genetic mouse model, co-immunoprecipitation, polyubiquitination assay, electrophysiology (LTP/LTD recordings), proteasome fractionation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reconstitution of ubiquitination mechanism, multiple orthogonal methods, defined genetic model\",\n      \"pmids\": [\"21565394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SHANK3 knockdown in neuronal cultures specifically reduces synaptic expression of mGluR5 (but not other major synaptic proteins), impairs mGluR5-dependent ERK1/2 and CREB phosphorylation, impairs mGluR5-dependent LTD, and reduces mEPSC frequency; these effects are rescued by a positive allosteric modulator of mGluR5.\",\n      \"method\": \"RNAi knockdown in neuronal cultures, western blot, immunofluorescence, electrophysiology (mEPSC recording, LTD), ERK/CREB phosphorylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, biochemistry, pharmacological rescue) in a well-controlled knockdown model\",\n      \"pmids\": [\"21795692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Zinc sequestration by amyloid-beta prevents association of Zn2+ ions with ProSAP2/SHANK3, leading to reduced ProSAP2/Shank3 at the PSD and decreased synapse density; zinc supplementation or pre-saturation of Aβ with zinc countered these effects, demonstrating zinc-dependent regulation of SHANK3 scaffold assembly.\",\n      \"method\": \"Cell-based Zn2+ binding assay, rat hippocampal cultures, zinc supplementation, immunofluorescence, synapse density quantification, APP-PS1 mouse model\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple in vitro and in vivo assays in single lab, zinc-SHANK3 interaction confirmed by cell-based assay\",\n      \"pmids\": [\"21939532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Synaptic levels of ProSAP2/SHANK3 regulate AMPA and NMDA receptor-mediated synaptic transmission and modulate presynaptic structure/function through Neurexin-Neuroligin transsynaptic signaling; ASD-associated mutations in SHANK3 disrupt both postsynaptic receptor signaling and transsynaptic signaling.\",\n      \"method\": \"Overexpression and knockdown in rat hippocampal neurons, electrophysiology (AMPAR/NMDAR EPSCs), immunofluorescence of pre/postsynaptic proteins\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple electrophysiological and biochemical readouts, single lab, defined pathway placement\",\n      \"pmids\": [\"23100419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SHANK3 expression restores excitatory synaptic transmission deficits in iPSC-derived neurons from Phelan-McDermid syndrome patients; IGF1 treatment promotes formation of mature excitatory synapses lacking SHANK3 but containing PSD95 and NMDA receptors, demonstrating SHANK3's role in excitatory synapse function in human neurons.\",\n      \"method\": \"iPSC-derived neurons from PMDS patients, lentiviral SHANK3 re-expression, IGF1 treatment, electrophysiology (synaptic transmission recordings), immunofluorescence\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human iPSC model with genetic rescue and pharmacological rescue, multiple orthogonal methods\",\n      \"pmids\": [\"24132240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Shank3 deficiency induces NMDA receptor hypofunction via actin cytoskeleton disruption through the Rac1/PAK/cofilin signaling pathway; Shank3 siRNA reduces NR1 surface expression and NMDAR currents, effects blocked by actin stabilizers and constitutively active Rac1 or PAK, and occluded by Rac1/PAK inhibitors or cofilin activation.\",\n      \"method\": \"siRNA knockdown in rat cortical cultures, whole-cell patch clamp (NMDAR currents), surface biotinylation, immunocytochemistry (F-actin), pharmacological manipulation of Rac1/PAK/cofilin pathway\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple pharmacological epistasis experiments plus electrophysiology plus surface expression assays establishing pathway mechanism\",\n      \"pmids\": [\"24089484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Rich2 (Rho-GAP interacting CIP4 homolog 2) is a new Shank3 binding partner identified by proteomics; Rich2-Shank3 interaction increases in dendritic spines during LTP; Rich2 controls AMPA receptor GluA1 exocytosis; disruption of the Rich2-Shank3 complex inhibits spine enlargement and GluA1 exocytosis during LTP.\",\n      \"method\": \"Proteomic screen, BRET microscopy, siRNA knockdown, interfering mimetic peptide, AMPA receptor exocytosis assay, spine morphology analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — proteomic identification confirmed by BRET, functional disruption via siRNA and peptide, multiple orthogonal readouts\",\n      \"pmids\": [\"23739967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ProSAP2/Shank3 undergoes activity-dependent synapse-to-nucleus shuttling in hippocampal neurons; a schizophrenia-associated de novo mutation (R1117X) causes constitutive nuclear accumulation independent of synaptic activity and alters transcription of schizophrenia risk genes (Synaptotagmin 1, LRRTM1), identifying novel nuclear interaction partners.\",\n      \"method\": \"Immunofluorescence, live imaging, activity manipulation (TTX/bicuculline), nuclear/synaptic fractionation, transcriptional analysis\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with functional consequence (transcriptional changes), single lab, multiple readouts\",\n      \"pmids\": [\"24382453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The Shank3 ankyrin repeat region is regulated by an intramolecular interaction with the adjacent SPN (Shank/ProSAP N-terminal) domain, which restricts access of ligands Sharpin and α-fodrin; ASD-associated L68P mutation disrupts this intramolecular blockade, resulting in a gain-of-function with enhanced binding to these ligands.\",\n      \"method\": \"Binding assays in heterologous cells, expression of wild-type and mutant Shank3 in neurons, electrophysiology (rescue experiments after knockdown)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional binding assays with mutagenesis plus electrophysiological validation, single lab\",\n      \"pmids\": [\"23897824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Shank3 gene displays extensive mRNA and protein isoforms from multiple intragenic promoters and alternative splicing; isoform expression is brain-region/cell-type specific, developmentally regulated, activity-dependent, and epigenetically controlled; different Shank3 isoforms show distinct subcellular distributions and differential effects on dendritic spine morphology in hippocampal neurons.\",\n      \"method\": \"RT-PCR, quantitative real-time RT-PCR, western blot, cellular imaging of isoform-specific GFP constructs in hippocampal neurons\",\n      \"journal\": \"Molecular autism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (RT-PCR, qPCR, western, imaging) with direct functional comparisons of isoforms, single lab\",\n      \"pmids\": [\"25071925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SHANK3 interacts with TRPV1 via its proline-rich region in dorsal root ganglion sensory neurons and regulates TRPV1 surface expression; Shank3 haploinsufficiency reduces capsaicin-induced spontaneous pain, DRG neuron inward currents, and spinal cord synaptic currents, establishing a peripheral mechanistic role for SHANK3 in pain signaling.\",\n      \"method\": \"Co-immunoprecipitation (SHANK3-TRPV1), surface expression assay, patch clamp electrophysiology, conditional knockout (Nav1.8-Cre), behavioral pain assays\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, surface expression, electrophysiology, and conditional KO with specific behavioral readout, multiple orthogonal methods\",\n      \"pmids\": [\"27916453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SHANK3 mutations severely and specifically impair hyperpolarization-activated cation (Ih) channels; SHANK3 protein interacts with HCN channel proteins (HCN1, HCN2, HCN4); chronic pharmacological blockage of Ih channels reproduces SHANK3 mutation phenotypes (altered neuronal morphology and synaptic connectivity), suggesting Ih channelopathy mediates downstream effects.\",\n      \"method\": \"Engineered conditional mutations in human neurons, electrophysiology (Ih current recording), co-immunoprecipitation (SHANK3-HCN), pharmacological Ih blockade, mouse Shank3-deficient neurons\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP identifying interaction, electrophysiology in human engineered neurons and mouse neurons, pharmacological phenocopy, multiple orthogonal methods\",\n      \"pmids\": [\"26966193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Shank3 deficiency causes down-regulation of Akt-mTORC1 signaling through enhanced phosphorylation and activation of PP2A regulatory subunit B56β due to increased steady-state levels of its kinase CLK2; pharmacological/genetic Akt activation or CLK2 inhibition relieves synaptic deficits in Shank3-deficient and PMDS patient-derived neurons.\",\n      \"method\": \"Quantitative phosphoproteomics, pharmacological and genetic manipulation (CLK2 inhibition, Akt activation), electrophysiology in patient iPSC-derived neurons, behavioral assays in Shank3-deficient mice\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — unbiased phosphoproteomics plus genetic and pharmacological validation in both mouse and human neurons, multiple orthogonal methods\",\n      \"pmids\": [\"26847545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Re-expression of Shank3 in adult mice (after developmental absence) improves synaptic protein composition, spine density, and neural function in the striatum, and rescues social interaction deficits and repetitive grooming, but not anxiety or motor coordination deficits, demonstrating partial reversibility of Shank3-dependent phenotypes.\",\n      \"method\": \"Conditional knock-in mouse model (inducible Shank3 re-expression), western blot, spine density analysis, electrophysiology, behavioral assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue in adult animals with multiple synaptic and behavioral readouts, well-controlled mouse model\",\n      \"pmids\": [\"26886798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Shank3 deficiency increases nuclear localization of β-catenin (a Shank3-binding protein), which induces HDAC2 upregulation and social deficits; HDAC2 knockdown in PFC rescues social deficits; romidepsin (HDAC inhibitor) treatment elevates expression and histone acetylation of Grin2a and actin-regulatory genes, restoring NMDA-receptor function and actin filaments.\",\n      \"method\": \"Co-immunoprecipitation (Shank3-β-catenin), nuclear fractionation, HDAC2 knockdown, HDAC inhibitor treatment, NMDA receptor electrophysiology, ChIP (histone acetylation), behavioral assays\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, nuclear fractionation, genetic knockdown, pharmacological rescue, and electrophysiology establishing pathway mechanism\",\n      \"pmids\": [\"29531362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Zinc stabilizes Shank3 at the postsynaptic density; zinc supplementation increases Shank3 labeling intensity at PSD and prevents reversal of NMDA-induced Shank3 accumulation, demonstrated by pre-embedding immunogold electron microscopy.\",\n      \"method\": \"Pre-embedding immunogold electron microscopy, depolarization (high K+) and NMDA treatment, zinc supplementation in dissociated rat hippocampal cultures\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ultrastructural localization with quantitative analysis, functional manipulation, single lab\",\n      \"pmids\": [\"27144302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Shank3 protein interaction with ZIP4 (zinc uptake transporter) was demonstrated by co-immunoprecipitation; SHANK3-deficient enterocytes show decreased expression of ZIP2 and ZIP4 correlating with SHANK3 levels, and reduced ZIP4 co-localizes with SHANK3 at the plasma membrane, identifying a role for SHANK3 in intestinal zinc homeostasis.\",\n      \"method\": \"Co-immunoprecipitation (ZIP4-SHANK3), SHANK3 knockdown in Caco-2 cells, iPSC-derived enterocytes from PMDS patients, immunohistochemistry in Shank3αβ KO mice\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing complex, knockdown and KO model, multiple model systems, single lab\",\n      \"pmids\": [\"28345660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SHANK3 regulates intestinal barrier function by modulating ZO-1 expression through a PKCε-dependent pathway; SHANK3 overexpression enhances ZO-1 expression while knockdown reduces it; SHANK3 KO mice show leaky epithelial barrier.\",\n      \"method\": \"SHANK3 overexpression/knockdown in intestinal epithelial cells, SHANK3 KO mouse model, TEER/paracellular permeability assays, western blot (ZO-1, PKCε), immunoblotting\",\n      \"journal\": \"Inflammatory bowel diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional manipulation (OE and KD) with defined molecular readout (ZO-1/PKCε) and in vivo KO confirmation, single lab\",\n      \"pmids\": [\"28906292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"USP8 is a deubiquitinating enzyme that regulates SHANK3 ubiquitination and protein levels; USP8 enhances SHANK3 and SHANK1 protein levels via deubiquitination, increases dendritic spine density, and is essential for activity-dependent changes in SHANK3 protein levels.\",\n      \"method\": \"Co-immunoprecipitation (USP8-SHANK3), ubiquitination assay, USP8 overexpression/knockdown in primary rat neurons, western blot, dendritic spine analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, deubiquitination assay, and bidirectional manipulation with functional readout (spine density, protein levels), single lab\",\n      \"pmids\": [\"29735556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"An ASD-linked missense variant at Shank3 S685 disrupts recruitment of ABI1 and the WAVE complex to the PSD, impairing synapse and dendritic spine development; this function is independent of Shank3's binding to GKAP and Homer, demonstrating modular independent functions of Shank3.\",\n      \"method\": \"In vivo phosphorylation profiling, co-immunoprecipitation (Shank3-ABI1/WAVE complex), knock-in mouse model with S685 mutation, dendritic spine analysis, behavioral assays\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing interaction, knock-in mouse model with behavioral and morphological readout, single lab\",\n      \"pmids\": [\"30610205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Conditional knockout of Shank3 in the anterior cingulate cortex (ACC) is sufficient to cause excitatory synaptic dysfunction and social interaction deficits; selective enhancement of ACC activity, SHANK3 restoration in ACC, or systemic AMPA receptor-positive modulator administration improved social behavior in Shank3 mutant mice.\",\n      \"method\": \"Conditional knockout (region-specific Cre), electrophysiology (excitatory synaptic transmission), behavioral assays, pharmacological rescue\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — circuit-selective genetic manipulation with defined synaptic and behavioral readouts, pharmacological rescue confirms pathway\",\n      \"pmids\": [\"31332372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ERK2 binds Shank3 directly and phosphorylates it at three residues to promote poly-ubiquitination-dependent degradation; genetic deletion or pharmacological inhibition of ERK2 increases Shank3 protein abundance in vivo.\",\n      \"method\": \"Kinome-wide siRNA screen, ERK2-Shank3 co-immunoprecipitation/binding, phosphorylation assay, ubiquitination assay, in vivo pharmacological/genetic ERK2 inhibition, western blot\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct binding, phosphorylation, and ubiquitination assays with in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"30696942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SHANK3 mutations increase histone methyltransferases EHMT1/2 and H3K9me2 in prefrontal cortex; EHMT1/2 inhibition or knockdown rescues autism-like social deficits and restores NMDAR-mediated synaptic function; Arc was identified as a causal downstream factor for NMDAR function rescue.\",\n      \"method\": \"Western blot (EHMT1/2, H3K9me2 in Shank3 KD mice and human postmortem brains), EHMT1/2 inhibitor (UNC0642) treatment, EHMT knockdown in PFC, electrophysiology (NMDAR currents), behavioral assays\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — convergent evidence from pharmacological and genetic inhibition, human postmortem confirmation, electrophysiology, and behavioral rescue\",\n      \"pmids\": [\"30659288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SHANK3 localizes to Z-discs in skeletal muscle sarcomeres and co-immunoprecipitates with α-ACTININ; SHANK3 deficiency leads to shortened Z-discs, impaired acetylcholine receptor clustering at neuromuscular junctions, and motor deficits rescued by troponin activator Tirasemtiv.\",\n      \"method\": \"Co-immunoprecipitation (SHANK3-α-ACTININ), immunofluorescence (Z-disc localization), hiPSC-derived myotubes, Shank3Δ11-/- mice, PMDS patient muscle biopsies, behavioral rescue with Tirasemtiv\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP establishing interaction, direct localization in multiple model systems including patient tissue, pharmacological rescue\",\n      \"pmids\": [\"32522805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CaMKIIα directly binds Shank3 between residues 829–1130; mutation of Shank3 residues 949Arg-Arg-Lys951 to alanines disrupts CaMKII binding; both Shank3 binding to CaMKII and to LTCCs is required for depolarization-induced CREB phosphorylation and c-Fos expression, establishing Shank3 as a required scaffold for LTCC-to-nucleus signaling.\",\n      \"method\": \"Co-immunoprecipitation from mouse forebrain, direct binding assay with purified CaMKIIα, site-directed mutagenesis, shRNA/rescue in hippocampal neurons, CREB phosphorylation and c-Fos expression assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct binding with purified protein, mutagenesis disrupting interaction, shRNA/rescue establishing functional requirement, multiple orthogonal methods\",\n      \"pmids\": [\"32019829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Truncating mutations in SHANK3 that remove postsynaptic targeting sequences expose a nuclear localization signal in the N-terminal part of the protein; truncated SHANK3 interacts with β-catenin via the PDZ domain of SHANK3 and armadillo repeats of β-catenin, sequestering both in nuclear bodies and strongly repressing β-catenin-dependent transcriptional activation.\",\n      \"method\": \"Subcellular localization analysis (immunofluorescence, fractionation), co-immunoprecipitation (truncated Shank3-β-catenin), luciferase transcriptional reporter assays, NLS identification and mutagenesis\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, direct localization, functional reporter assay establishing transcriptional repression, single lab\",\n      \"pmids\": [\"32202324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Two ASD-associated missense mutations in SHANK3 cause distinct changes in secondary and tertiary protein structure, increased conformational fluctuations (by SAXS and biophysical analysis), and result in altered synaptic targeting and changes in protein turnover at synaptic sites in rat primary hippocampal neurons.\",\n      \"method\": \"SAXS, biophysical structural analysis, FRAP in rat hippocampal neurons, synaptic localization analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — structural analysis (SAXS) plus neuronal functional experiments, single lab\",\n      \"pmids\": [\"33945465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SHANK3 directly interacts with actin through its SPN domain; this interaction is inhibited by an intramolecular closed conformation where the adjacent ARR domain covers the actin-binding interface; actin and Rap1 compete for binding to SHANK3; SHANK3-actin interaction regulates dendritic spine morphology in neurons.\",\n      \"method\": \"Molecular simulations, targeted mutagenesis, actin co-sedimentation assay, co-immunoprecipitation, dendritic spine morphology analysis in neurons, integrin activity assay in cancer cells\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct binding assay, mutagenesis confirming interface, molecular simulations, and neuronal functional validation\",\n      \"pmids\": [\"34610274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Phosphorylation of Shank3 at S1586 and S1615 bidirectionally gates homeostatic synaptic scaling: sites are hypophosphorylated during scaling up (via PP2A activity) and hyperphosphorylated during scaling down; phosphomimetic mutations prevent scaling up while phosphodeficient mutations prevent scaling down; these phosphorylation states modify Shank3 synaptic localization.\",\n      \"method\": \"Deep-scale quantitative phosphoproteomics, immunoaffinity isolation, phosphomimetic/phosphodeficient mutagenesis, PP2A pharmacological inhibition, synaptic scaling assay, Shank3 synaptic localization analysis in neocortical neurons\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — phosphoproteomics combined with mutagenesis, pharmacological intervention, and functional assays in a single integrated study\",\n      \"pmids\": [\"35471151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SHANK3 interacts with STIM1 via direct binding and promotes proteasome-mediated degradation of STIM1; STIM1 downregulation via SHANK3 induces Nrf2 Ser40 phosphorylation, Nrf2 nuclear translocation, and upregulation of antioxidant genes (NQO1, HO-1), protecting against ischemia/reperfusion-induced oxidative stress and inflammation.\",\n      \"method\": \"Co-immunoprecipitation (Shank3-STIM1), Shank3 conditional KO and double KO (Shank3+Stim1), western blot (Nrf2, NQO1, HO-1), in vitro HT22 cell assays, in vivo I/R mouse model\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing interaction, genetic rescue with double KO validating pathway, single lab\",\n      \"pmids\": [\"38064762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CTTNBP2 facilitates SHANK3 co-condensation at dendritic spines through liquid-liquid phase separation; zinc binding to CTTNBP2 promotes liquid-to-gel phase transition, reducing CTTNBP2 mobility and enhancing stability/synaptic retention of CTTNBP2-SHANK3 condensates.\",\n      \"method\": \"Co-condensation assays, FRAP, phase separation assays, zinc supplementation, ASD mutation analysis, behavioral assays in mice\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct condensate co-assembly assays, FRAP, and in vivo behavioral validation, single lab\",\n      \"pmids\": [\"35562389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ADNP interacts with SHANK3 and actin in mouse brain extracts; NAP (ADNP-derived peptide) normalizes Shank3-Adnp-actin interactions as shown by actin co-immunoprecipitation, and NAP treatment ameliorates behavior in Shank3 InsG3680 mutant mice.\",\n      \"method\": \"Co-immunoprecipitation (Shank3-Adnp-actin) from mouse brain, NAP treatment, behavioral assays in Shank3 InsG3680 mice\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing three-way complex, pharmacological rescue confirming functional relationship, single lab\",\n      \"pmids\": [\"35538192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cardiac Shank3 directly binds CaMKII (demonstrated by IP assay), and this interaction increases in the aged heart; enhanced Shank3/CaMKII binding impedes mitochondrial translocation of CaMKII, inhibiting Parkin-mediated mitophagy and causing mitochondrial dysfunction and cardiac damage.\",\n      \"method\": \"Co-immunoprecipitation (cardiac Shank3-CaMKII), cardiac-specific Shank3 conditional KO, mitophagy assays, mitochondrial function assays\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing interaction, conditional KO establishing functional role in cardiac mitophagy, single lab\",\n      \"pmids\": [\"36436456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Shank3 in vagal sensory neurons (nodose ganglion) regulates TRPM2 expression; Shank3 deficiency in Nav1.8-expressing sensory neurons or selective Shank3 knockdown in vagal neurons impairs body temperature regulation and increases LPS-induced systemic inflammation (IL-6), identifying a peripheral, non-synaptic role for SHANK3.\",\n      \"method\": \"Conditional Shank3 KO (Nav1.8-Cre), Shank3/Trpm2 knockdown in nodose ganglion, RNAscope in situ hybridization, LPS inflammation model, body temperature measurement\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO plus selective knockdown with defined molecular readout (TRPM2 expression), functional inflammatory phenotype, single lab\",\n      \"pmids\": [\"36845137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ProSAPiP2 is a novel binding partner of ProSAP2/SHANK3 PDZ domain, expressed in neurons, localized to dendrites and spines and enriched in the PSD; it interacts with actin, potentially linking PSD components to the cytoskeleton.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, PSD fractionation, actin binding assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP and co-localization, limited functional follow-up, single lab\",\n      \"pmids\": [\"19481056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-7, miR-34a, and miR-504 post-transcriptionally regulate SHANK3 expression through direct binding sites in the 3' UTR; overexpression or inhibition of miR-7 and miR-504 affected dendritic spines in hippocampal neurons in a Shank3-dependent manner.\",\n      \"method\": \"Luciferase reporter assay (miRNA 3' UTR binding), lentiviral miRNA overexpression in hippocampal neurons, western blot, spine morphology analysis\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase assay confirming direct 3' UTR binding, functional validation in neurons via lentiviral overexpression, single lab\",\n      \"pmids\": [\"26572867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Shank3 deficiency causes Ih channelopathy in thalamocortical neurons; Shank3 increases HCN channel surface expression in heterologous systems; Shank3Δ13-16 deficiency causes reduction in HCN2 expression and Ih current amplitude, altered resting membrane potential, increased input resistance, and abnormal spike firing—phenotypes resembling HCN2-/- TC neurons.\",\n      \"method\": \"Heterologous expression of Shank3 isoforms with HCN channels (surface expression assay), electrophysiology (Ih current recording) in thalamocortical neurons from Shank3 KO mice, comparison with HCN2-/- mice\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — surface expression assay plus electrophysiology in specific neuronal type, confirmed by phenotypic comparison with HCN2 KO, multiple isoform comparison\",\n      \"pmids\": [\"29327340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Shank3 mutation (InsG3680) impairs glutamatergic signaling in oligodendrocytes and reduces expression of myelination-related transcripts and proteins in vivo; SHANK3 has a postsynaptic role in oligodendrocyte precursor cells similar to its role in neurons, and SHANK3 deficiency impairs myelin ultrastructure and axonal conductivity.\",\n      \"method\": \"InsG3680 mouse model, iPSC-derived OLs from patient with InsG3680 mutation, electrophysiology (OPC glutamatergic responses), western blot, electron microscopy (myelin ultrastructure), axonal conductivity measurement\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods including patient-derived cells, in vivo and in vitro validation, single lab\",\n      \"pmids\": [\"39392881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Shank3 SAM domain-mediated oligomerization is essential for the PSD condensate to form a glass-like material state through network percolation; disruption of Shank3 SAM oligomerization softens the PSD condensate, impairs synaptic transmission and plasticity, and causes autistic-like behavior in mice; reconstituted PSD condensate forms a soft glass material without irreversible amyloid structure.\",\n      \"method\": \"Reconstituted PSD condensate (in vitro phase separation), rheology (material property measurement), SAM domain oligomerization mutagenesis, electrophysiology (synaptic transmission/plasticity), behavioral assays in knock-in mice\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution of PSD condensate with rheological characterization, mutagenesis establishing mechanism, in vivo genetic validation with synaptic and behavioral readouts\",\n      \"pmids\": [\"40848728\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SHANK3 is a multi-domain postsynaptic scaffold protein at excitatory synapses whose SAM domain drives oligomerization and glass-like PSD condensate formation; it organizes glutamate receptor complexes (NMDAR, AMPAR, mGluR5) and HCN channels via direct interactions with GKAP/SAPAP, Homer, neuroligins, HCN proteins, CaMKII, TRPV1, ABI1/WAVE complex, and actin (through its SPN domain), while its synaptic levels are dynamically regulated by zinc, activity-dependent phosphorylation (ERK2-mediated ubiquitin-proteasome degradation, PP2A-mediated dephosphorylation gating homeostatic scaling, and USP8-mediated deubiquitination), epigenetic mechanisms (DNA methylation, HDAC2/EHMT1/2-dependent histone modifications), and miRNAs; outside the CNS, SHANK3 also regulates peripheral pain (via TRPV1 surface expression in DRG neurons), intestinal barrier function (via PKCε-ZO-1 pathway), zinc transporter expression in enterocytes, vagal neuron temperature/immune regulation (via TRPM2), and skeletal muscle sarcomere integrity (via α-ACTININ at Z-discs).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SHANK3 (ProSAP2) is a master postsynaptic scaffold of excitatory glutamatergic synapses that physically links membrane receptors to the actin cytoskeleton and, through self-assembly, organizes the material properties of the postsynaptic density (PSD) [#0, #44]. Its PDZ domain binds the SAPAP/GKAP family to bridge PSD-95-associated receptors to deeper scaffold and cytoskeletal layers [#0], while SAM domain-mediated oligomerization drives the PSD to behave as a glass-like condensate whose stiffness is required for normal synaptic transmission and plasticity [#44]. Loss of SHANK3 reduces synaptic Homer1b/c, GKAP, GluA1, mGluR5 and NMDAR subunits and impairs LTP/LTD, AMPAR redistribution, and mGluR5-dependent signaling [#5, #6, #7], in part by disrupting Rac1/PAK/cofilin-dependent actin dynamics and NMDAR surface expression [#11]; SHANK3 also binds actin directly through its SPN domain under conformational control by the adjacent ARR domain [#33]. Beyond passive scaffolding, SHANK3 couples synaptic activity to the nucleus, serving as a required adaptor for CaMKIIα- and L-type calcium channel-driven CREB phosphorylation and c-Fos induction [#30], and it nucleates dynamic signaling complexes with Rich2, the ABI1/WAVE complex, HCN channels, and CTTNBP2 to control spine morphology, AMPAR exocytosis, Ih currents, and zinc-tuned condensate stability [#12, #25, #17, #36]. SHANK3 abundance at synapses is tightly regulated by zinc binding [#8, #21], by ubiquitin-proteasome turnover controlled by ERK2-mediated phosphorylation and USP8-mediated deubiquitination [#27, #24], by PP2A-gated phosphorylation that bidirectionally controls homeostatic scaling [#34], and by DNA methylation, miRNAs, and downstream chromatin-modifying pathways (β-catenin/HDAC2, EHMT1/2) [#3, #41, #20, #28]. SHANK3 deficiency models Phelan-McDermid syndrome and autism-associated phenotypes, with synaptic and behavioral deficits reversible by re-expression of SHANK3 or pharmacological restoration of downstream pathways [#10, #19, #26]. Outside the CNS, SHANK3 performs analogous scaffolding roles, regulating TRPV1 in nociceptors [#16], TRPM2 in vagal neurons [#39], intestinal barrier and zinc transport [#22, #23], skeletal muscle Z-disc integrity via α-ACTININ [#29], and cardiac mitophagy via CaMKII [#38].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing how postsynaptic receptors couple to deeper scaffold and cytoskeleton, the discovery that SHANK3's PDZ domain binds SAPAP/GKAP positioned SHANK3 as the physical link between PSD-95-bound receptors and the cytoskeleton.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal Co-IP, and co-transfection in HEK cells\",\n      \"pmids\": [\"10527873\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define higher-order scaffold assembly\", \"No in vivo functional consequence shown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"To explain how SHANK3 is delivered to synapses, deletion mapping identified a C-terminal SAM-domain-containing targeting signal required for postsynaptic localization.\",\n      \"evidence\": \"GFP-tagged deletion constructs and live imaging in hippocampal neurons\",\n      \"pmids\": [\"15659222\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular partners mediating targeting not identified\", \"Mechanism of SAM-dependent targeting not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Addressing why SHANK3 is expressed tissue-specifically, CpG island methylation was shown to causally control SHANK3 (but not SHANK1/2) protein levels.\",\n      \"evidence\": \"Bisulfite sequencing with methionine and 5-Aza-2′-deoxycytidine pharmacology and western blot\",\n      \"pmids\": [\"17419801\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Methyl-binding effectors not identified\", \"Link to disease-relevant expression changes not established\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genetic loss-of-function mouse and knockdown studies established SHANK3 as essential for excitatory synapse composition, plasticity, and circuit function, defining its role in striatal/cortico-striatal connectivity and receptor-specific deficits (Homer1b/c, GKAP, GluA1, mGluR5, NMDAR).\",\n      \"evidence\": \"Multiple Shank3 deletion mouse models with electrophysiology, PSD fractionation, and RNAi rescue\",\n      \"pmids\": [\"21423165\", \"21558424\", \"21565394\", \"21795692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Different exon deletions yield partially distinct phenotypes\", \"Isoform-specific contributions not yet separated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"To explain how SHANK3 mutations destabilize the scaffold, a C-terminal truncation was shown to drive polyubiquitination and proteasomal redistribution of wild-type SHANK3 and NMDAR NR1, linking mutation to dominant scaffold loss.\",\n      \"evidence\": \"Co-IP, polyubiquitination assays, and LTP/LTD electrophysiology in a Shank3ΔC mouse\",\n      \"pmids\": [\"21565394\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase not identified at this stage\", \"Generalizability to other truncations unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying an upstream regulator of scaffold assembly, zinc was shown to be required for SHANK3 PSD localization, with amyloid-beta-mediated zinc sequestration reducing synaptic SHANK3 and synapse density.\",\n      \"evidence\": \"Cell-based Zn2+ binding assays, hippocampal cultures, and APP-PS1 mice with zinc supplementation\",\n      \"pmids\": [\"21939532\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Zinc-binding site on SHANK3 not mapped here\", \"Stoichiometry of zinc effect unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Expanding the partner network, proteomic and binding studies identified Rich2 and clarified intramolecular autoinhibition (SPN–ARR) controlling Sharpin/α-fodrin access, linking SHANK3 conformation to spine plasticity and AMPAR exocytosis.\",\n      \"evidence\": \"Proteomic screen, BRET, interfering peptides, and binding assays with ASD mutants\",\n      \"pmids\": [\"23739967\", \"23897824\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of the conformational switch in vivo not defined\", \"Cross-talk between ligand sets not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Establishing transsynaptic and nuclear roles, SHANK3 was shown to modulate Neurexin-Neuroligin presynaptic function and to undergo activity-dependent synapse-to-nucleus shuttling that alters transcription, with a schizophrenia mutation causing constitutive nuclear accumulation.\",\n      \"evidence\": \"Overexpression/knockdown electrophysiology and nuclear/synaptic fractionation with transcriptional analysis\",\n      \"pmids\": [\"23100419\", \"24382453\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear interaction partners incompletely defined\", \"Physiological significance of shuttling in vivo unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"To resolve how SHANK3 controls NMDAR function, knockdown was shown to drive NMDAR hypofunction through Rac1/PAK/cofilin-mediated actin disruption and reduced NR1 surface expression.\",\n      \"evidence\": \"siRNA knockdown, surface biotinylation, and pharmacological epistasis on the Rac1/PAK/cofilin pathway\",\n      \"pmids\": [\"24089484\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical link between SHANK3 and Rac1/PAK not shown\", \"Whether actin effect is direct or scaffold-mediated unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Human-cell validation: SHANK3 re-expression restored excitatory transmission deficits in Phelan-McDermid syndrome iPSC neurons, and IGF1 provided a SHANK3-independent rescue, anchoring SHANK3 function in human disease neurons.\",\n      \"evidence\": \"PMDS patient iPSC neurons with lentiviral SHANK3 rescue, IGF1 treatment, and electrophysiology\",\n      \"pmids\": [\"24132240\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of IGF1 bypass not defined\", \"Long-term/in vivo translatability unaddressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Characterizing SHANK3 complexity, multiple intragenic promoters and splicing were shown to generate isoforms with distinct localization, regulation, and spine effects, explaining cell-type and activity specificity.\",\n      \"evidence\": \"RT-PCR, qPCR, western blot, and imaging of isoform-specific GFP constructs\",\n      \"pmids\": [\"25071925\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional roles of individual isoforms incompletely mapped\", \"Isoform-specific partner repertoires unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Post-transcriptional control of SHANK3 was established via direct miRNA targeting of its 3'UTR (miR-7, miR-34a, miR-504), affecting spine morphology in a SHANK3-dependent manner.\",\n      \"evidence\": \"Luciferase 3'UTR reporters and lentiviral miRNA manipulation in hippocampal neurons\",\n      \"pmids\": [\"26572867\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological contexts engaging each miRNA unclear\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extending SHANK3 beyond the CNS, its proline-rich region was shown to bind TRPV1 and regulate TRPV1 surface expression in DRG neurons, defining a peripheral role in pain signaling.\",\n      \"evidence\": \"Co-IP, surface expression assays, conditional Nav1.8-Cre knockout, and behavioral pain assays\",\n      \"pmids\": [\"27916453\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether scaffolding mechanism mirrors CNS PSD role unclear\", \"Other peripheral TRPV1 contexts untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"SHANK3 was shown to bind HCN channel subunits and control Ih currents, identifying an Ih channelopathy as a downstream mediator of SHANK3 mutation phenotypes.\",\n      \"evidence\": \"Co-IP, Ih electrophysiology in engineered human and mouse neurons, and pharmacological Ih blockade phenocopy\",\n      \"pmids\": [\"26966193\", \"29327340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Domain mediating HCN binding not fully mapped\", \"Relative contribution of Ih vs glutamatergic deficits unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Mechanistic and therapeutic insight into reversibility came from Akt-mTORC1/PP2A-B56β/CLK2 signaling deficits and adult SHANK3 re-expression rescuing synaptic and select behavioral phenotypes.\",\n      \"evidence\": \"Phosphoproteomics with genetic/pharmacological CLK2-Akt manipulation, and inducible adult Shank3 re-expression mouse\",\n      \"pmids\": [\"26847545\", \"26886798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why some phenotypes (anxiety, motor) are irreversible unknown\", \"Direct vs indirect link of SHANK3 to PP2A/CLK2 unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linking SHANK3 to chromatin, β-catenin/HDAC2 signaling was shown to mediate social deficits, with HDAC inhibition restoring NMDAR function and actin gene expression.\",\n      \"evidence\": \"Co-IP, nuclear fractionation, HDAC2 knockdown, romidepsin treatment, ChIP, and behavior\",\n      \"pmids\": [\"29531362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How synaptic SHANK3 loss elevates nuclear β-catenin not fully defined\", \"Direct chromatin targets incompletely cataloged\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Peripheral epithelial roles emerged: SHANK3 binds ZIP4 to control intestinal zinc transport and regulates barrier integrity through a PKCε-ZO-1 pathway.\",\n      \"evidence\": \"Co-IP, knockdown in Caco-2/iPSC enterocytes, and Shank3 KO mice with permeability assays\",\n      \"pmids\": [\"28345660\", \"28906292\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting SHANK3 to PKCε not defined\", \"Relationship between zinc transport and barrier roles unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"USP8 was identified as a deubiquitinase stabilizing SHANK3, establishing reversible ubiquitination as a control point for activity-dependent SHANK3 levels and spine density.\",\n      \"evidence\": \"Co-IP, deubiquitination assays, and bidirectional USP8 manipulation in rat neurons\",\n      \"pmids\": [\"29735556\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase counterpart not jointly defined here\", \"Activity signals driving USP8 engagement unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The kinase coupling SHANK3 degradation to signaling was identified as ERK2, which directly binds and phosphorylates SHANK3 to promote ubiquitin-dependent turnover, complementing modular roles defined by the S685/ABI1-WAVE axis.\",\n      \"evidence\": \"Kinome-wide screen, binding/phosphorylation/ubiquitination assays, in vivo ERK2 inhibition, and S685 knock-in mouse with Co-IP\",\n      \"pmids\": [\"30696942\", \"30610205\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the E3 ligase remains undefined\", \"Interplay between ERK2 phosphosites and other regulatory sites unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Circuit- and chromatin-level mechanisms were refined: ACC-restricted SHANK3 loss is sufficient for social deficits rescuable by AMPAR potentiation, and EHMT1/2-driven H3K9me2 (via Arc) mediates NMDAR and behavioral deficits.\",\n      \"evidence\": \"Region-specific conditional KO with pharmacological rescue, and EHMT1/2 inhibition/knockdown with human postmortem confirmation and electrophysiology\",\n      \"pmids\": [\"31332372\", \"30659288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How synaptic SHANK3 loss elevates EHMT1/2 not defined\", \"Generalizability across brain regions partially open\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"SHANK3 was established as a required adaptor for activity-to-nucleus signaling through direct CaMKIIα binding (residues 829–1130; RRK949-951) coupling LTCCs to CREB/c-Fos, and direct SPN-domain actin binding under ARR-conformational and Rap1-competitive control.\",\n      \"evidence\": \"Direct binding with purified CaMKIIα, mutagenesis, shRNA/rescue, actin co-sedimentation, and molecular simulations\",\n      \"pmids\": [\"32019829\", \"34610274\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How conformational opening is triggered physiologically unclear\", \"Integration of CaMKII and actin functions not unified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Non-neuronal scaffolding roles were defined in skeletal muscle, where SHANK3 binds α-ACTININ at Z-discs to maintain sarcomere and NMJ integrity, with pharmacological rescue of motor deficits.\",\n      \"evidence\": \"Co-IP, Z-disc immunofluorescence in myotubes, Shank3 mice, patient biopsies, and Tirasemtiv rescue\",\n      \"pmids\": [\"32522805\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether muscle role uses same domains as PSD scaffolding unclear\", \"Contribution to PMDS motor phenotype quantification incomplete\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The transcriptional-repression mechanism of truncated SHANK3 was clarified: truncations expose an N-terminal NLS, and the PDZ domain binds β-catenin armadillo repeats to sequester both in nuclear bodies and repress β-catenin transcription.\",\n      \"evidence\": \"Fractionation, Co-IP, NLS mutagenesis, and luciferase reporter assays\",\n      \"pmids\": [\"32202324\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of nuclear sequestration not established\", \"Target gene set repressed not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Biophysical analyses tied ASD missense mutations to altered protein structure, conformational flexibility, synaptic targeting, and turnover, connecting molecular destabilization to synaptic dysfunction.\",\n      \"evidence\": \"SAXS, biophysical structural analysis, and FRAP in rat hippocampal neurons\",\n      \"pmids\": [\"33945465\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"High-resolution structures not determined\", \"Direct link from conformational change to specific binding losses unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Phase-separation principles entered SHANK3 biology: CTTNBP2 promotes SHANK3 co-condensation, and zinc drives a liquid-to-gel transition stabilizing synaptic condensates, mechanistically integrating zinc regulation with material-state control.\",\n      \"evidence\": \"Co-condensation/phase separation assays, FRAP, zinc supplementation, and mouse behavior\",\n      \"pmids\": [\"35562389\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship to SAM-domain oligomerization not unified here\", \"Endogenous zinc dynamics governing transition unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Homeostatic plasticity control was assigned to PP2A-gated SHANK3 phosphorylation at S1586/S1615, which bidirectionally gates synaptic scaling and modifies SHANK3 synaptic localization.\",\n      \"evidence\": \"Deep-scale phosphoproteomics, phosphomimetic/phosphodeficient mutagenesis, PP2A inhibition, and scaling assays\",\n      \"pmids\": [\"35471151\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase(s) opposing PP2A at these sites not identified\", \"How phosphorylation alters localization mechanistically unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Additional peripheral and signaling roles were defined: SHANK3 binds STIM1 to promote its degradation and engage Nrf2 antioxidant signaling, binds cardiac CaMKII to regulate mitophagy, and forms ADNP-actin complexes amenable to NAP rescue.\",\n      \"evidence\": \"Co-IP, conditional/double KO models, mitophagy/oxidative assays, and NAP behavioral rescue\",\n      \"pmids\": [\"38064762\", \"36436456\", \"35538192\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tissue-specific generality of these interactions unclear\", \"Shared vs distinct domains used for each partner undefined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A vagal-neuron role was established whereby SHANK3 regulates TRPM2 expression to control body temperature and systemic inflammation, extending non-synaptic peripheral functions.\",\n      \"evidence\": \"Conditional KO, vagal knockdown, RNAscope, and LPS inflammation model\",\n      \"pmids\": [\"36845137\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking SHANK3 to TRPM2 transcription unclear\", \"Direct physical interaction not demonstrated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"SHANK3 function was extended to oligodendrocyte lineage cells, where mutation impairs glutamatergic signaling, myelination transcripts, myelin ultrastructure, and axonal conductivity, broadening its role beyond neurons.\",\n      \"evidence\": \"InsG3680 mice, patient iPSC-derived oligodendrocytes, electrophysiology, and electron microscopy\",\n      \"pmids\": [\"39392881\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether oligodendrocyte SHANK3 uses the same PSD machinery unclear\", \"Contribution of myelin deficits to behavior not quantified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The unifying biophysical principle was established: SAM-domain oligomerization drives the PSD condensate into a glass-like material state via network percolation, and disrupting it softens the condensate, impairs plasticity, and causes autistic-like behavior.\",\n      \"evidence\": \"Reconstituted PSD condensate with rheology, SAM oligomerization mutagenesis, electrophysiology, and knock-in mouse behavior\",\n      \"pmids\": [\"40848728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How material state mechanistically tunes receptor signaling unclear\", \"Regulators of glass-state transition in vivo undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SHANK3's many regulatory inputs (zinc, phosphorylation, ubiquitination, conformational state, phase separation) are integrated in real time to set PSD composition and material properties, and which E3 ligase executes ERK2/ubiquitin-dependent degradation, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase for SHANK3 degradation unidentified\", \"Unified model linking condensate material state to receptor signaling missing\", \"Domain logic distinguishing CNS scaffolding from peripheral roles undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 30, 33]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [33, 11, 29]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [16, 17, 42, 35, 22]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [44, 36]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [16, 22, 17]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [13, 31, 20]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [33, 11, 29]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 4, 5, 6, 7, 44]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [30, 18, 11]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [6, 27, 24]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [20, 28, 3]}\n    ],\n    \"complexes\": [\"postsynaptic density (PSD)\", \"WAVE regulatory complex (ABI1/WAVE)\"],\n    \"partners\": [\"GKAP/SAPAP\", \"Homer1\", \"CaMKII\", \"HCN2\", \"TRPV1\", \"ACTN2 (α-ACTININ)\", \"CTNNB1 (β-catenin)\", \"CTTNBP2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}